triazoles has been researched along with fluconazole in 743 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 119 (16.02) | 18.7374 |
| 1990's | 90 (12.11) | 18.2507 |
| 2000's | 247 (33.24) | 29.6817 |
| 2010's | 248 (33.38) | 24.3611 |
| 2020's | 39 (5.25) | 2.80 |
| Authors | Studies |
|---|---|
| Bava, AJ; Negroni, R | 1 |
| Anaissie, E; Bodey, G; Gokaslan, A; Griffin, G; Hachem, R; Robinson, R; Rubin, R; Sobel, J | 1 |
| Benrubi, GI; Griffin, CR; Magee, MJ; Parker, R; Slavin, MB | 1 |
| Foleno, B; Fu, KP; Isaacson, D; LoCoco, J | 1 |
| Antonacci, B; Cacciapuoti, A; Hare, RS; Loebenberg, D; Menzel, F; Miller, GH; Moss, EL; Norris, C; Parmegiani, R; Yarosh-Tomaine, T | 1 |
| Agorio, I; Costa, MR; Finquelievich, JL; Iovannitti, C; Loebenberg, D; Negroni, R; Tiraboschi, IN | 1 |
| Graybill, JR; Sharkey, PK | 1 |
| Brummer, E; Hanson, LH; Stevens, DA | 1 |
| Hector, RF; Yee, E | 1 |
| Defaveri, J; Graybill, JR; Sun, SH | 1 |
| Perfect, JR; Ritter, W; Wright, KA | 1 |
| Defaveri, J; Graybill, JR; Rinaldi, MG; Salazar, MH | 1 |
| Ichise, K; Nakajima, T; Okuda, T; Tanio, T | 1 |
| Bacher, J; Kelly, P; Lecciones, J; Lee, JW; Peter, J; Pizzo, PA; Thomas, V; Walsh, TJ | 1 |
| Fierer, J; Finley, F; Kirkland, T | 1 |
| Lambert, C; Meunier, F; Van der Auwera, P | 1 |
| Kobayashi, GS; Medoff, G; Rinaldi, MG; Travis, SJ | 1 |
| Noble, L; Picard, M; Sugar, AM | 1 |
| Clemons, KV; Hanson, LH; Perlman, AM; Stevens, DA | 1 |
| Antinori, S; Esposito, R; Foppa, CU | 1 |
| Bunin, N; Camitta, B | 1 |
| Bille, J; Cajot, A; Chave, JP; Glauser, MP | 1 |
| Helenglass, G; Jones, A; Milliken, S; Powles, R | 1 |
| Dietrich, D | 1 |
| Cohen, J | 1 |
| Kawasaki, K; Matsunaga, T; Uchida, K; Yamaguchi, H | 1 |
| Fukawa, H; Kodama, F; Maruta, A; Matsuzaki, M | 1 |
| Nakashima, M | 1 |
| Hanawa, T; Hatakenaka, R; Ikeda, S; Katsura, A; Kosaba, S; Lee, Y; Matsubara, Y; Ninomiya, K; Shiota, T; Yagi, K | 1 |
| Hino, J; Moriya, O; Nakajima, M; Niki, Y; Soejima, R; Tsukiyama, K; Watanabe, M; Yagi, S | 1 |
| Adachi, M; Ikeda, H; Kawanishi, M; Matsushima, T; Nakamura, J; Tanabe, J; Tano, Y; Tomizawa, S | 1 |
| Arai, S; Iguchi, K; Kamiya, H; Sakurai, M | 1 |
| Miyahara, T; Saito, A; Shiba, K | 1 |
| Nito, H | 1 |
| Goto, H; Goto, M; Mori, H; Nakata, H; Oka, S; Shimada, K; Tokitsu, M | 1 |
| Yoneda, R | 1 |
| Hojo, H; Lin, KY; Torii, Y; Toyama, K; Tsuda, A; Yoshikawa, O | 1 |
| Ebe, T; Hamamoto, T; Hibiya, I; Inagaki, M; Isonuma, H; Kohara, T; Matsumura, M; Mori, T; Takahashi, M; Watanabe, K | 1 |
| Akahonai, Y; Ikemoto, H; Kasai, M; Kawamura, K; Mikuni, C; Mori, T; Taniuchi, A; Watanabe, K; Yoshida, K; Yoshida, T | 1 |
| Dupont, B | 1 |
| Bernard, DB; Idelson, BA; Saunders, C; Sugar, AM | 1 |
| Keil, TU | 1 |
| Mattie, H; van Furth, R; Van t Wout, JW | 1 |
| Lamey, PJ; Lewis, MA; MacDonald, DG | 1 |
| Bernard, DB; Farnham, H; Idelson, BA; Levine, J; Saunders, C; Sugar, AM | 1 |
| Foulds, G; Pizzo, PA; Walsh, TJ | 1 |
| Holland, JT; Mitchell, AS | 1 |
| Bozzette, S; Chiu, J; Larsen, RA; Leal, MA; McCutchan, JA; Richman, DD | 1 |
| Martin, MV | 1 |
| Charuel, C; Latrille, F; Lodola, A | 1 |
| Foulds, G; Harris, SC; Rinaldi, MG; Wallace, JE | 1 |
| Kobayashi, GS; Spitzer, ED | 1 |
| Graybill, JR | 1 |
| Ansmann, EB; Herzog, RE | 1 |
| Goldberg, DJ; Green, ST; Kennedy, DH; McGuire, W; Nathwani, D | 1 |
| Crook, D; Devenport, MH; Lees, LJ; Wynn, V | 1 |
| Knight, AG; Philpot, CM; Shuttleworth, D | 1 |
| Ebden, P; Farrow, PR; Neill, P | 1 |
| Fransen, J; Janssen, PA; Van Cutsem, J; Van Gerven, F | 1 |
| Bordi, E; Galgani, S; Leoni, GC; Narciso, P; Sette, P; Tozzi, V; Visco, G | 1 |
| Ellis-Pegler, RB; Thomas, MG | 1 |
| Fisher, MA; Lee, PG; Tarry, WF | 1 |
| Galgiani, JN; McIntyre, KA | 1 |
| Ahrens, J; Graybill, JR; Restrepo, BI | 1 |
| Durack, DT; Hobbs, MM; Perfect, JR; Wright, KA | 1 |
| Dave, J; Hickey, MM; Wilkins, EG | 1 |
| Corris, PA; Dark, JH; Freeman, R; Gould, FK; Kirk, AJ | 1 |
| Clumeck, N; De Wit, S; Goossens, H; Weerts, D | 1 |
| Kidd, D; Morris, TC; Ranaghan, EA | 1 |
| Clements, D; Holmes, J | 1 |
| Collignon, P; Hurley, B; Mitchell, D | 1 |
| Ehninger, G; Jaschonek, K; Krüger, HU; Schuler, U | 1 |
| Polak, A | 1 |
| Arndt, CA; Balis, FM; McCully, CL; Pizzo, PA; Poplack, DG; Walsh, TJ | 1 |
| Houston, JB; Humphrey, MJ; Matthew, DE; Tarbit, MH | 1 |
| Coats, M; Fiscella, R; Peyman, G; Schulman, JA; Small, G; Steahly, L; Wajszczuk, CP | 1 |
| Byrne, WR; Wajszczuk, CP | 1 |
| Kobayashi, GS; Medoff, G; Travis, SJ | 1 |
| Dismukes, WE; Saag, MS | 1 |
| Walsh, TJ | 1 |
| Beggs, WH; Bennett, RL; Hughes, CE; Tuna, IC | 1 |
| Arathoon, EG; Hanson, LH; Hartstein, AI; Levine, BE; Stevens, DA; Tucker, RM; Williams, PL | 1 |
| Senior, DS; Shaw, JT | 1 |
| Drouhet, E; Dupont, B | 3 |
| Abadie, SM; Greer, DL; Noel, SB; Pankey, GA; Zachary, JA | 1 |
| Dismukes, WE | 1 |
| Mattie, H; van Furth, R; Van't Wout, JW | 1 |
| Brennan, DR; Catanzaro, A; Foulds, G; Garg, DC; Knopf, W; Rinaldi, M; Wajszczuk, C; Weidler, DJ | 1 |
| Hanger, DP; Jevons, S; Shaw, JT | 1 |
| de Graeff-Meeder, ER; Kuis, W; Paul, LC; van 't Wout, JW; van Furth, R | 1 |
| Isalska, BJ; Stanbridge, TN | 1 |
| Coulaud, JP; Ngo Van, P | 1 |
| Drew, RH; Gallis, HA; Perfect, JR | 1 |
| Burke, JP; Classen, DC; Smith, CB | 1 |
| Bigot, MC; Debruyne, D; Moulin, M; Ryckelynck, JP | 1 |
| Graybill, JR; Hartman, BJ; Murray, HW; Rowland, V; Sharkey, P; Squires, KE; Stern, JJ | 1 |
| Saunders, C; Sugar, AM | 1 |
| Pizzo, A; Walsh, TJ | 1 |
| Gordon, MA; Lapa, EW; Passero, PG | 1 |
| Beach, DH; Goad, LJ; Holz, GG | 1 |
| Bähr, V; Eckhoff, C; Oelkers, W | 1 |
| Odds, FC; Webster, CE | 1 |
| Clayton, YM; Hay, RJ | 1 |
| Faergemann, J | 1 |
| Cooper, K; Marriott, MS; Richardson, K; Tarbit, MH; Troke, PF; Whittle, PJ | 1 |
| Foulds, G; Garg, DJ; Gibson, P; Wajszczuk, C; Weidler, DJ | 1 |
| Brammer, KW; Feczko, JM | 1 |
| Hay, RJ | 1 |
| Stevens, DA | 1 |
| Brammer, KW; Kutzer, E; Leodolter, S; Oittner, R | 1 |
| Budtz-Jørgensen, E; Holmstrup, P; Krogh, P | 1 |
| Hendel, L; Kieffer, M; Stenderup, A; Svejgaard, E; Walsøe, I | 1 |
| Burke, J; Cope, NJ; Johnson, EM; von Fraunhofer, NA; Warnock, DW; Williams, EW | 1 |
| Brammer, KW; Marriott, MS; Richardson, K; Troke, PF | 1 |
| Durack, DT; Perfect, JR | 1 |
| Andrews, RJ; Brammer, KW; Marriott, MS; Richardson, K; Troke, PF | 1 |
| Humphrey, MJ; Jevons, S; Tarbit, MH | 1 |
| Durack, DT; Perfect, JR; Savani, DV | 1 |
| Kobayashi, GS; Medoff, G; Travis, S | 1 |
| Ahrens, J; Graybill, JR; Sun, SH | 1 |
| Hopwood, V; Johnson, EM; Kennedy, CT; Smith, KJ; Van Cutsem, J; Vanden Bossche, H; Warnock, DW | 1 |
| Diamond, RD; Lyman, CA; Sugar, AM | 1 |
| Graybill, JR; Palou de Fernandez, E; Patino, MM; Tarbit, MH | 1 |
| Ahrens, J; Graybill, JR; Palou, E | 1 |
| Abbott, AB; Cheesman, SL; Odds, FC | 1 |
| Galgiani, JN; Rogers, TE | 1 |
| Tarbit, MH; Wood, PR | 1 |
| Cobo, LM; Durack, DT; Perfect, JR; Savani, DV | 1 |
| Beggs, WH; Hughes, CE | 1 |
| Dixon, DM; Polak, A | 1 |
| Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF | 1 |
| Abruzzo, GK; Fromtling, RA; Giltinan, DM; Turnbull, TA | 1 |
| Staben, C | 1 |
| Clemons, KV; Homola, ME; Stevens, DA | 1 |
| Ehninger, G; Mölle, M; Schuler, U | 1 |
| Denning, DW; Law, D; Mason, C; Moore, CB; Wardle, HM | 1 |
| Graybill, JR; Holmberg, JD; Luther, MF; Najvar, LK | 1 |
| Anaissie, EJ; Dignani, MC; Karyotakis, NC | 1 |
| Clemons, KV; Stevens, DA | 3 |
| Bale, MJ; Buschelman, B; Pfaller, MA; Rhomberg, P | 1 |
| Gearhart, MO | 1 |
| Ervine, CM; Houston, JB | 1 |
| Atkinson, BA; Bocanegra, R; Colombo, AL; Graybill, JR | 1 |
| Bartlett, MS; Queener, SF; Richardson, JD; Shaw, MM; Smith, JW | 1 |
| Antonacci, B; Cacciapuoti, A; Hare, RS; Loebenberg, D; Menzel, F; Miller, GH; Moss, L; Norris, C; Parmegiani, RM; Yarosh-Tomaine, T | 1 |
| Clemons, KV; Hanson, LH; Stevens, DA | 1 |
| Bastide, JM; Janbon, F; Le Guennec, R; Mallié, M; Pujol, C; Reynes, J | 1 |
| Liu, XP; Sugar, AM | 1 |
| Denning, DW; Kelly, SL; Manning, NJ; Venkateswarlu, K | 1 |
| Cox, GM; Dodge, RK; Perfect, JR; Schell, WA | 1 |
| Barry, AL; Brown, SD | 1 |
| Hata, K; Katsu, K; Kimura, J; Miki, H; Nakamura, T; Toyosawa, T | 1 |
| Hata, K; Katsu, K; Kimura, J; Miki, H; Moriyama, M; Toyosawa, T | 1 |
| Elmquist, WF; Wang, Q; Yang, H | 2 |
| Correa, A; Graybill, JR; James, P; Luther, MF; Najvar, LK | 1 |
| Chanock, SJ; Walsh, TJ | 1 |
| Annen, N; Araki, H; Fujimaki, K; Hayakawa, H; Hori, R; Imaizumi, H; Narita, H; Nishida, N; Shimizu, K; Watanbe, Y; Yamamoto, S; Yotsuji, A | 1 |
| Cooper, CR; McGinnis, MR | 1 |
| Jones, RN; Messer, S; Pfaller, MA | 1 |
| Ruhnke, M; Schmidt-Westhausen, A; Trautmann, M | 1 |
| Hollis, RJ; Pfaller, MA; Zhang, J | 1 |
| Grunwaldt, G; Nega, E | 1 |
| Carver, PL; Kauffman, CA | 1 |
| Cutright, JL; Fidel, PL; Sobel, JD | 1 |
| Denning, DW; Kelly, SL; Venkateswarlu, K | 1 |
| Denning, DW; Law, D; Moore, CB | 1 |
| Aristizabal, BH; Stevens, DA | 1 |
| Belanger, P; Fratti, R; Ghannoum, M; Sanati, H | 1 |
| Haberreiter, A; Paule, I; Seidl, HP; Wildfeuer, A | 1 |
| Hernanz Hermosa, JM; Lázaro Ochaita, P | 1 |
| Jones, RN; Marco, F; Messer, S; Pfaller, MA | 1 |
| Gubbins, PO; Penzak, SR | 1 |
| Cartledge, JD; Clumeck, N; De Wit, S; Denning, DW; Dupont, B; Gazzard, BG; Hawkins, DA; Midgley, J | 1 |
| Belanger, PH; Fratti, RA; Ghannoum, MA; Sanati, H | 1 |
| Brummer, E; Purimetla, N; Stevens, DA; Vora, S | 1 |
| Kauffman, CA; Zarins, LT | 2 |
| Cantu, RA; Fothergill, AW; Kirkpatrick, WR; Lopez-Ribot, JL; Mcatee, RK; McCarthy, DI; Patterson, TF; Revankar, SG; Rinaldi, MG; Sanche, SE | 1 |
| Nguyen, MH; Yu, CY | 1 |
| Brummer, E; Kamei, K; Miyaji, M | 2 |
| Cooper, CR; Fothergill, AW; McGinnis, MR; Pasarell, L; Rinaldi, MG; Sutton, DA | 1 |
| Diehl, V; Fätkenheuer, G; Hegener, P; Ruhnke, M; Troke, PF | 1 |
| Brandt, ME; Ghannoum, MA; Hajjeh, RA; Jessup, CJ; Mbidde, EK; Messer, SA; Pfaller, MA; Tumberland, M; Zhang, J | 1 |
| Aoki, FH; Branchini, ML; Mikami, Y; Miyaji, M; Nishimura, K; Taguchi, H; Yamamoto, K; Yang, HC; Yazawa, K | 1 |
| Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
| Bhat, N; Ghannoum, MA; Okogbule-Wonodi, I; Sanati, H | 1 |
| Atkinson, G; Denning, DW; Hollis, S; Hood, SV; Percy, M; Williams, K | 1 |
| Hoban, DJ; Karlowsky, JA; Zhanel, GG | 1 |
| Amalfitano, G; Concia, E; Kwon-Chung, KJ; Luzzati, R; Mondon, P; Petter, R; Polacheck, I | 1 |
| Cuenca-Estrella, M; Díaz-Guerra, TM; Mellado, E; Monzón, A; Rodríguez-Tudela, JL | 1 |
| Anaissie, EJ; Arikan, S; Lozano-Chiu, M; Paetznick, VL; Rex, JH | 1 |
| Ghannoum, M; Koul, A; Reyes, G; Vitullo, J | 1 |
| Diekema, DJ; Doern, GV; Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Cuenca-Estrella, M; Monzón, A; Ramos, G; Rodríguez-Tudela, JL | 1 |
| Kikuchi, M; Kojima, M; Mikami, Y; Mochizuki, H; Nakamura, S; Nakanishii, T; Takahashi, Y; Yamada, H | 1 |
| Bonner, DP; Fung-Tomc, JC; Huczko, E; Minassian, B; White, TC | 1 |
| Al-Abdely, HM; Graybill, JR; Loebenberg, D; Melby, PC | 1 |
| Patterson, TF | 1 |
| Amoroso, A; Garrido, D; Gutkind, G; Hochenfellner, F; Moretton, J; Pizzorno, MT; Radice, M; Rodero, L; Segall, A | 1 |
| Ringdahl, EN | 1 |
| Barchiesi, F; Graybill, JR; Luther, MF; Najvar, LK; Restrepo, MI | 1 |
| Niki, Y | 1 |
| Arzeni, D; Barchiesi, F; Carle, F; Caselli, F; Di Cesare, S; Di Francesco, LF; Fallani, S; Fortuna, M; Giacometti, A; Giannini, D; Mazzei, T; Novelli, A; Scalise, G; Schimizzi, AM | 1 |
| Cassone, A; Girmenia, C; Martino, P; Monaco, M; Mondello, F; Santilli, S; Tuccinardi, C | 1 |
| Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA; Yamazumi, T | 1 |
| Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O | 1 |
| Lee, JK; Noskin, GA; Obias, AA; Peters, D; Peterson, LR | 1 |
| Leitner, I; Ryder, NS | 1 |
| Karlsson, I; Kronvall, G | 1 |
| Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
| Boyle, K; Espinel-Ingroff, A; Sheehan, DJ | 1 |
| Crego, AL; Gómez, J; Lavandera, JL; Marina, ML | 1 |
| Diekema, DJ; Fluit, AC; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA; Sader, HS | 1 |
| Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Aguirrebengoa, K; Ally, R; Carosi, G; Dupont, B; Hodges, M; Kreisel, W; Romero, AJ; Schürmann, D; Troke, P | 1 |
| Feng, XT; Liu, CM; Ma, MC; Wu, YJ; Zhang, DZ; Zhou, TS | 1 |
| Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
| Fukuoka, T; Harada, Y; Harasaki, T; Inoue, S; Kamai, Y; Konosu, T; Mori, M; Nakagawa, A; Nakamura, Y; Ohya, S; Oida, S; Seki, S; Seta, Y; Shibayama, T; Somada, A; Uchida, T; Yasuda, H | 1 |
| Ernst, EJ; Klepser, ME; Roling, EE; Yodoi, K | 1 |
| Arzeni, D; Barchiesi, F; D'Angelo, M; Falconi Di Francesco, L; Giuliana, G; Milici, ME; Pizzo, G; Scalise, G | 1 |
| Calderon, L; Clemons, KV; Martinez, M; Stevens, DA | 1 |
| Fothergill, AW; Gonzalez, G; Perea, S; Rinaldi, MG; Sutton, DA | 1 |
| Ellepola, AN; Samaranayake, LP | 1 |
| DE Carolis, E; Loranger, L; Marcotte, H; Pelletier, R | 1 |
| Barry, A; Brown, S; Traczewski, M | 1 |
| Bernhardt, H; Bernhardt, J; Knoke, M; Zimmermann, K | 1 |
| Dorrell, L; Edwards, A | 1 |
| Darouiche, RO; Kontoyiannis, DP; Lewis, RE; Prince, RA; Raad, II | 1 |
| Fothergill, AW; Rinaldi, MG; Sutton, DA; Yildiran, ST | 1 |
| Fukuoka, T; Hosokawa, T; Kamai, Y; Kubota, M; Kuwahara, S; Maeda, N; Shibayama, T; Uchida, K; Yamaguchi, H | 1 |
| Kottom, TJ; Limper, AH; Morales, IJ; Puri, V; Thomas, CF; Vohra, PK | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Maxwell, MJ; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
| Bruneau, JM; Caer, JP; Fudali, C; Hodgson, J; Labas, V; Lecaque, D; Legrand, R; Maillet, I; Supatto, F; Tagat, E | 1 |
| Burt, C; de Groot, MJ; Filler, SG; Fukuoka, T; Hitchcock, CA; Johnston, DA; Winslow, CA | 1 |
| Kamei, K | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA | 2 |
| Bayer, A; Edwards, JE; Rieg, G; Spellberg, B | 1 |
| Chen, E; Matar, MJ; Ostrosky-Zeichner, L; Paetznick, VL; Rex, JH; Rodriguez, JR | 1 |
| Matysiak, J; Niewiadomy, A | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Tendolkar, S | 2 |
| del Palacio, A; Garau, M; Pereiro, M | 1 |
| Benito, R; Gil, J; Ramírez de Ocáriz, I; Rezusta, A; Rubio Calvo, MC | 1 |
| Andes, D; Conklin, R; Marchillo, K; Stamstad, T | 1 |
| Chávez-Caballero, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Serrano-Martino, Mdel C; Valverde-Conde, A | 1 |
| Kontoyiannis, DP; Lewis, RE; Lionakis, MS; Liu, W; May, GS; Wiederhold, N | 1 |
| Bliss, JM; Gigliotti, F; Wellington, M | 1 |
| Baron, EJ; Colombo, AL; de Bedout, C; del Palacio, A; Gibbs, DL; Girmenia, C; Hazen, KC; Sanchez-Sousa, A | 1 |
| Bartroli, J; Benjamin, DK; Boyce, M; Miller, JL; Perfect, JR; Schell, WA; Toffaletti, DL; Wills, EA | 1 |
| Maertens, JA | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Rice, C; Tendolkar, S | 3 |
| Höhl, R | 1 |
| Adou-Bryn, KD; Buisson, Y; Chandenier, J; Douchet, C; Kombila, M; Richard-Lenoble, D; Sar, B; Swinne, D; Thérizol-Ferly, M | 1 |
| Nolard, N; Swinne, D; Van der Flaes, M; Watelle, M | 1 |
| Bocanegera, R; Colombo, AL; Gonzalez, GM; Graybill, JR; Hernandez, S; McCarthy, DI; Najvar, LK | 1 |
| Chang, CS; Chang, HW; Chang, WN; Chien, CC; Huang, CR; Lee, PY; Lei, CB; Lu, CH | 1 |
| Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
| Bernhardt, H; Bernhardt, J; Knoke, M; Ludwig, K | 1 |
| Cheng, HH; Lo, HJ; Yang, YL | 1 |
| Al-Fattani, MA; Douglas, LJ | 1 |
| Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE | 1 |
| Jones, AL; Pai, MP | 1 |
| D'Antonio, D; Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I | 1 |
| Chiodo, F; Consales, A; Manfredi, R; Pavoni, M; Sabbatani, S | 1 |
| Wingard, JR | 1 |
| Burn, AK; Coco, BJ; Fothergill, AW; Kirkpatrick, WR; McCarthy, DI; Patterson, TF; Redding, SW; Rinaldi, MG | 1 |
| Marr, K | 1 |
| Perfect, JR | 1 |
| Alonso, R; Carrillo-Muñoz, AJ; del Valle, O; Hernández-Molina, JM; Loebenberg, D; McNicholas, P; Quindós, G; Ruesga, M; Santos, P | 1 |
| Burkhardt, O; Köhnlein, T; Pletz, M; Welte, T | 1 |
| Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Viudes, A | 1 |
| Yasuda, MA | 1 |
| Ji, HT; Miao, ZY; Sheng, CQ; Song, YL; Yang, S; Yao, JZ; Yu, JX; Zhang, M; Zhang, WN; Zhu, J | 1 |
| Nolard, N; Swinne, D; Watelle, M | 1 |
| Batra, R; Gupta, AK; Kohli, Y | 1 |
| Baltch, AL; Bopp, LH; Carlyn, CJ; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
| Steinbach, WJ | 1 |
| Kofla, G; Ruhnke, M | 1 |
| Hoshiko, S; Ohtsuka, K; Okutomi, T; Takahata, S; Uchida, K; Yamaguchi, H | 1 |
| Coco, BJ; Fothergill, AW; Kirkpatrick, WR; Oliveira, ER; Patterson, TF; Redding, SW | 1 |
| Cao, YB; Cao, YY; Gao, PH; Gu, J; Jia, XM; Jiang, YY; Li, RY; Wang, Y; Xu, Z; Zhang, JD; Zhang, WN | 1 |
| Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE | 1 |
| Cetinkaya, Z; Kiraz, N | 1 |
| Cárdenes, CD; Carrillo-Muñoz, AJ; Carrillo-Orive, B; Casals, JB; Del Valle, O; Ezkurra, PA; Quindós, G; Rodríguez, V | 1 |
| Costa-de-Oliveira, S; Mårdh, PA; Pina-Vaz, C; Ricardo, E; Rodrigues, AG | 1 |
| Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE | 1 |
| Bagg, J; Brailsford, S; Davies, AN; Jackson, MS; Sweeney, MP | 1 |
| Alía-Aponte, C; Baró-Tomás, T; Jiménez-Cabello, T; Lázera, MS; Morera-López, Y; Torres-Rodríguez, JM | 1 |
| Bishara, J; Peled, N; Samra, Z; Yardeni, M | 1 |
| Niwa, T; Shiraga, T; Takagi, A | 1 |
| Alexander, BD; Long, GD; Miller, JL; Perfect, JR; Schell, WA | 1 |
| Colombo, GL; Morlotti, L; Serra, G | 1 |
| Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW | 1 |
| Herrin, KV; Loebenberg, D; Miranda, A | 1 |
| Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G | 1 |
| Baró-Tomás, T; Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM | 1 |
| Barnes, R; Diekema, DJ; Gibbs, DL; Hu, B; Nagy, E; Pfaller, MA; Rinaldi, MG; Tiraboschi, N; Veselov, AV | 1 |
| Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Choti, M; Magill, SS; Merz, WG; Sears, CL; Shields, C | 1 |
| Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T | 1 |
| Abdel-Alim, AA; Hashem, M; Hussein, MA; Mohamed, BG | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Casadevall, A; Martinez, LR | 1 |
| Andes, D; Chaturvedi, V; Diekema, DJ; Espinel-Ingroff, A; Ghannoum, MA; Johnson, EM; Odds, FC; Pfaller, MA; Rex, JH; Rinaldi, MG; Sheehan, DJ; Troke, P; Walsh, TJ; Warnock, DW | 1 |
| Gogate, J; Greaves, W; Isaacs, R; Nieto, L; Northland, R; Sanne, I; Skiest, DJ; Vazquez, JA | 1 |
| Brizendine, E; Connolly, P; Durkin, M; Goldman, M; Mann, P; McNicholas, PM; Patel, R; Smedema, M; Wheat, LJ | 1 |
| Gribskov, JL; Kirby, KA; Marr, KA; Panackal, AA; Rinaldi, M; Staab, JF | 1 |
| Alves, SH; Azevedo, AC; Boff, E; Da Matta, DA; Guarro, J; Loreto, ES; Santurio, JM | 1 |
| Anstead, GM; Graybill, JR; Martinez, M | 1 |
| Hynninen, VV; Laine, K; Leino, K; Lundgren, S; Neuvonen, PJ; Olkkola, KT; Rane, A; Valtonen, M; Vyyryläinen, H | 1 |
| Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F | 1 |
| Akova, M; Sahin, GO | 1 |
| Ghannoum, M; Isham, N; Sheehan, D | 1 |
| Pemán, J; Zaragoza, R | 1 |
| Hapuarachchi, S; Jayasinghe, S; Perera, KN; Ranwala, R; Rodrigo, N; Warnakulasuriya, A | 1 |
| Barcs, I; Dóczi, I; Mestyán, G; Nagy, E; Nikolova, R; Puskás, E | 1 |
| Lill, H; Voigt, C | 1 |
| Georgopoulos, A; Graninger, W; Kratzer, C; Schmoll, M; Tobudic, S | 1 |
| Manfredi, R; Sabbatani, S | 1 |
| Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
| Chang, SC; Diekema, DJ; Erzsebet, P; Gibbs, DL; Kibbler, C; Mendez, M; Newell, VA; Pfaller, MA | 1 |
| Colombo, AL; Diekema, DJ; Gibbs, DL; Kibbler, C; Newell, VA; Ng, KP; Pfaller, MA | 1 |
| Gopal, L; Sen, P; Sen, PR | 1 |
| Guarro, J; Marimon, R; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Fukuoka, N; Houchi, H; Ishida, T; Kawazoe, H; Ohnishi, H; Takiguchi, Y; Tanaka, H | 1 |
| Carratalà, J; Garcia-Vidal, C | 1 |
| Canton, E; Espinel-Ingroff, A; Gibbs, D; Wang, A | 1 |
| Costa, CR; de Araujo, CR; de Fátima Lisboa Fernandes, O; do Rosário Rodrigues Silva, M; Miranda, KC; Passos, XS | 1 |
| Anstead, GM; Boparai, N; Graybill, JR; Hare, R; Isaacs, R; Reynes, J; Skiest, DJ; Vazquez, JA; Ward, D | 1 |
| Hutzler, JM; Locuson, CW; Tracy, TS | 1 |
| Boparai, N; Chandrasekar, P; Durrant, S; Greinix, H; Langston, A; Lipton, JH; Morais de Azevedo, W; Patino, H; Pedicone, L; Reddy, V; Tarantolo, SR; Ullmann, AJ; Vesole, DH | 1 |
| Angulo-Gonzalez, D; Cornely, OA; Goh, YT; Hardalo, C; Helfgott, D; Holowiecki, J; Maertens, J; Perfect, J; Petrini, M; Stockelberg, D; Suresh, R; Ullmann, AJ; Walsh, TJ; Winston, DJ | 1 |
| De Pauw, BE; Donnelly, JP | 1 |
| Barchiesi, F; Borowski, E; Milewski, S; Morschhäuser, J; Prasad, R; Wakieć, R | 1 |
| Cheng, S; Clancy, CJ; Clapp, W; Nguyen, KT; Nguyen, MH | 1 |
| da Silva Barros, ME; de Assis Santos, D; Soares Hamdan, J | 1 |
| Araújo, CR; Costa, CR; e Souza, LK; Fernandes, Ode F; Nascimento, ES; Passos, XS; Sales, WS; Silva, Mdo R | 1 |
| Easley, C; Kauffman, CA; Kirkpatrick, P; Malani, AN | 1 |
| Carrillo-Munoz, AJ; Casals, JB; Eraso, E; Quindos, G; Rementeria, A; Rodriguez Andres, C; Sanchez-Vargas, LO; Villar, M | 1 |
| Alvarado-Ramírez, E; Torres-Rodríguez, JM | 1 |
| Colombo, AL; Diekema, DJ; Fu, W; Gibbs, DL; Gould, IM; Meis, JF; Newell, VA; Pfaller, MA; Rodriguez-Noriega, E | 1 |
| Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
| Bosques, F; Garza, E; González, G; González, GM; Robledo, E; Saldívar, D | 1 |
| Aoun, N; Baixench, MT; Bretagne, S; Dannaoui, E; Desnos-Ollivier, M; Garcia-Hermoso, D; Piketty, C; Ramires, S | 1 |
| Harada, AS; Lau, W | 1 |
| Falusi, E; Gergely, L; Kardos, G; Majoros, L; McNicholas, PM; Sóczó, G | 1 |
| Duflos, M; Le Baut, G; Le Borgne, M; Le Pape, P; Lebouvier, N; Na, YM; Pagniez, F | 1 |
| Aller, AI; Castro, C; Claro, R; Colom, MF; Martín-Mazuelos, E; Serrano, C | 1 |
| Gupta, A; Mao, Q; Unadkat, JD | 1 |
| Bellmann, R; Weiler, S | 1 |
| van Dissel, JT; van Nieuwkoop, C | 1 |
| Krause, DS | 1 |
| Cárdenes, CD; Carrillo-Muñoz, AJ; del Valle, O; Estivill, D; Giusiano, G; Guardia, C; Guarro, J; Quindós, G; Rodríguez, V | 1 |
| Bocanegra, R; Graybill, JR; Kirkpatrick, WR; Najvar, LK; Patterson, TF | 1 |
| Dannaoui, E; Datry, A; Dromer, F; Hoinard, D; Lacroix, C; Lortholary, O; Paugam, A; Poirot, JL; Raoux, D | 1 |
| Maida, CM; Milici, ME; Oliveri, S | 1 |
| Barnes, RA; Kuriyama, T; Lewis, MA; Noake, T; Potts, AJ; White, PL; Williams, DW | 1 |
| Choe, L; Guglielmo, BJ; Inciardi, J; Martin, T; Riedel, A; Yuen, C | 1 |
| Haas, A; Maschmeyer, G | 1 |
| Calderone, R; Chauhan, N; Kruppa, M | 1 |
| Bertilsson, L; Laine, K; Neuvonen, PJ; Olkkola, KT; Saari, TI | 1 |
| Chen, SC; Sorrell, TC | 1 |
| Casadevall, A; Gácser, A; Martinez, LR; Nosanchuk, JD; Ntiamoah, P | 1 |
| Chang, CL; Kim, MN; Kim, SH; Lee, HS; Lee, JS; Lee, K; Lee, WG; Ryang, DW; Shin, BM; Shin, JH; Shin, MG; Suh, SP; Uh, Y | 1 |
| Laine, K; Neuvonen, M; Neuvonen, PJ; Olkkola, KT; Saari, TI | 1 |
| Khakoo, RA; Khan, FA; Slain, D | 1 |
| Brusca, MI; Finquelievich, JL; Gliosca, LA; Jewtuchowicz, VM; Lovannitti, CA; Mujica, MT; Rosa, AC | 1 |
| Alkorta, M; Eraso, E; Hernández-Almaraz, JL; Quindós, G; Sánchez-Vargas, LO; Villar-Vidal, M | 1 |
| Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW | 1 |
| Carrillo-Muñoz, AJ; Casals, JB; del Valle, O; Estivill, MD; Ezkurra, PA; Giusiano, G; Quindós, G; Santos, P | 1 |
| Arechavala, AI; Bianchi, MH; Negroni, R; Robles, AM; Santiso, G | 1 |
| Barnes, R; Colombo, A; Diekema, DJ; Finquelievich, J; Gibbs, DL; Newell, VA; Ng, KP; Pfaller, MA; Wadula, J | 1 |
| Bouza, E; Guinea, J; Peláez, T; Recio, S; Torres-Narbona, M | 1 |
| Almyroudis, NG; Gonzalez, AV; Segal, BH; Ullmann, AJ | 1 |
| Andes, D; Smith, J | 1 |
| Alvarado-Ramírez, E; Murciano, F; Sellart, M; Torres-Rodríguez, JM | 1 |
| Barchiesi, F; Giannini, D; Maida, CM; Milici, ME; Orlando, F; Scalise, G; Spreghini, E; Tomassetti, S | 1 |
| Hussein, MA; Kfafy, Ael-H; Mostafa, YA; Radwan, AA | 1 |
| Akşit, F; Kiraz, N; Kiremitçi, A; Oz, Y | 1 |
| Chu, CC; Hsueh, PR; Ruan, SY | 1 |
| Jiang, Y; Jin, Y; Li, P; Liu, P; Sun, P; Sun, Q; Wu, Q; Xie, W; Yang, X; Zhang, D; Zhang, Y; Zhu, S | 1 |
| Ishida, S; Matsui, H; Nishimura, Y; Okano, Y; Oyama, TB; Oyama, TM; Oyama, Y; Sakanashi, Y; Yokota, S | 1 |
| Cuenca-Estrella, M; Dos Anjos Martins, M; Gomez-Lopez, A; Melhem, MC; Rodriguez-Tudela, JL; Zaragoza, O | 1 |
| Karthaus, M | 1 |
| Ayala, J; Elizondo, M; González, GM | 1 |
| Dolande, M; Panizo, MM; Reviákina, V; Selgrad, S | 1 |
| Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A | 1 |
| Hollenbach, E | 1 |
| Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N | 1 |
| Jansen, JP; Janssen, JJ; Lugtenburg, E; O'Sullivan, AK; Rijnders, B; Span, LF; Stam, WB | 1 |
| Amiri, F; Assadpour, E; Hossaini, Z; Khabnadideh, S; Pakshir, K; Rezaei, Z | 1 |
| Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L | 1 |
| Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P | 1 |
| Adani, GL; Baccarani, U; Baraldo, M; Cojutti, P; Franceschi, L; Furlanut, M; Londero, A; Pea, F; Tavio, M; Viale, P | 1 |
| Choi, CW; Joo, SI; Kim, BS; Kim, EC; Kim, TU; Kim, YK; Lee, KM; Lee, YS; Yoo, JI; Yun, SH | 1 |
| Buchta, V; Vale-Silva, LA; Vejsova, M | 1 |
| Anderson, R; Steel, HC; Tintinger, GR | 1 |
| Brusca, MI; Iovannitti, CA; Jewtuchowicz, VM; Malzone, MC; Mujica, MT; Pola, SJ; Rosa, AC; Sordelli, N | 1 |
| Fothergill, AW; Patterson, TF; Thompson, GR; Vallor, AC; Wickes, BL; Wiederhold, NP | 1 |
| Kagoshima, Y; Konosu, T; Oida, S; Somada, A; Uchida, T | 1 |
| Calandra, T; Eggimann, P; Playford, EG | 1 |
| Bijie, H; Diekema, DJ; Dzierzanowska, D; Gibbs, DL; Klimko, NN; Letscher-Bru, V; Lisalova, M; Muehlethaler, K; Newell, VA; Pfaller, MA; Rennison, C; Zaidi, M | 1 |
| Denning, DW; Majithiya, J; Parmar, A; Sharp, A; Warn, PA | 1 |
| Cubillos, GF; Kett, DH | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Touw, DJ; Verweij, PE | 1 |
| Collins, CD; Ellis, JJ; Kaul, DR | 1 |
| Niimi, K; Niimi, M; Tanabe, K | 1 |
| Maesaki, S; Tarumoto, N | 1 |
| Fujii, Y; Inase, N; Yoshizawa, Y | 1 |
| dos Santos Lazéra, M; Guarro, J; Pastor, FJ; Pujol, I | 1 |
| Tu, EY | 1 |
| Aher, NG; Bhat, MK; Kumar, A; Mishra, NN; Pore, VS; Sharma, A; Shukla, PK | 1 |
| Nawrot, U; Nowicka, J; Wlodarczyk, K | 1 |
| Guggemos, W; Hecht, A; Rüdisser, K; Seilmaier, M | 1 |
| Fatuzzo, F; Iacobello, C; La Rosa, R; Larocca, L; Montineri, A; Nigro, L | 1 |
| Chan, RC; Pinto, A | 1 |
| Allizond, V; Banche, G; Carlone, N; Cuffini, AM; Fucale, G; Malabaila, A; Mandras, N; Roana, J; Robbiano, F; Scalas, D; Tullio, V | 1 |
| Chandy, R; Chehadeh, W; Chowdhary, A; Khan, ZU; Kowshik, T; Randhawa, HS | 1 |
| Chai, X; Dan, Z; Hu, H; Wu, Q; Yu, S; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
| Marti, J | 1 |
| Schwartz, S; Thiel, E | 1 |
| Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M | 1 |
| Adel, N; Harnicar, S; Jurcic, J | 1 |
| Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R | 1 |
| Costa-de-Oliveira, S; Pina-Vaz, C; Pinto e Silva, AT; Rodrigues, AG; Silva-Dias, A | 1 |
| Aguirre, JM; Carrillo-Muñoz, AJ; Eraso, E; Gaitán-Cepeda, LA; Quindós, G; Sánchez Vargas, LO | 1 |
| De Carolis, E; Fadda, G; Fiori, B; Florio, AR; La Sorda, M; Martucci, R; Posteraro, B; Sanglard, D; Sanguinetti, M | 1 |
| Bulut, Y; Günday, E; Güven, M; Yenişehirli, G | 1 |
| Nagawade, RR; Sangshetti, JN; Shinde, DB | 1 |
| Ambudkar, SV; Manoharlal, R; Prasad, R; Prasad, T; Puri, N; Sharma, M; Shukla, S | 1 |
| Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL | 1 |
| Andrade, SE; Elizondo, M; González, GM; Portillo, OJ; Robledo, M; Rodríguez, C; Uscanga, GI | 1 |
| Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
| Asticcioli, S; Daturi, R; Matti, C; Nucleo, E; Pagani, L; Sacco, L; Zara, F | 1 |
| Fung, CP; Lee, N; Lee, SC; Lo, HJ; See, LC | 1 |
| Accoceberry, I; Bernadou, JM; Breilh, D; Gordien, JB; Pigneux, A; Rouault, A; Saux, MC; Tabrizi, R; Vigouroux, S | 1 |
| Alp, S; Arikan, S; Hasçelik, G; Sancak, B | 1 |
| Elizondo, M; Garza-González, E; González, GM; González, JG; Robledo, E | 1 |
| Alex, A; Harvey, S; Parsons, T; Pullen, FS; Riley, JA; Wright, P | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
| Atienzar, M; Blanch, JJ; Escribano, E; Rodríguez, M | 1 |
| Anasetti, C; Field, T; Gergis, U; Greene, J; Huang, Y; Kharfan-Dabaja, M; Markey, K; Perkins, J; Schell, MJ; Wetzstein, G | 1 |
| Costa, CR; de Aquino Lemos, J; de Fátima Lisboa Fernandes, O; do Rosário Rodrigues Silva, M; Hasimoto e Souza, LK; Jesuíno, RS; Passos, XS | 1 |
| Cao, Y; Che, X; Ji, H; Miao, Z; Sheng, C; Wang, W; Yao, J; Zhang, W | 1 |
| Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A | 1 |
| Black, TA; Chau, AS; Cornely, OA; Mann, PA; McNicholas, PM; Mendrick, C; Patel, R; Patino, H; Ullmann, AJ | 1 |
| Carreras, E; Casado, MA; de la Cámara, R; Grau, S; Jarque, I; Sabater, FJ; Sanz, MA | 1 |
| Boikov, D; Nagappan, V; Vazquez, JA | 1 |
| Azeredo, J; Henriques, M; Martins, M; Negri, M; Oliveira, R; Svidzinski, TI | 1 |
| Bueno, JG; Gallego, M; Martinez, C; Mesa, AC; Sanclemente, G; Zapata, B | 1 |
| Bertout, S; Bourgeois, N; Bousquet, PJ; Dehandschoewercker, L; Lachaud, L; Rispail, P | 1 |
| Ikeda, R; Miyamoto, M; Nishikawa, A; Sugita, T; Takatori, K; Tsuboi, R | 1 |
| Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ | 1 |
| Adiri, Y; Karatela, S; Lyon, GM; Sunay, S | 1 |
| Diekema, DJ; Ellis, D; Fu, W; Gibbs, DL; Ling, TA; Newell, VA; Pfaller, MA; Rodloff, A; Tullio, V | 1 |
| Dag, I; Kasifoglu, N; Kiraz, N; Kiremitci, A; Oz, Y; Yamac, M | 1 |
| Besse, B; Hennequin, C; Le Pape, P; Loge, C; Morio, F | 1 |
| Barton, R; Bijie, H; Bille, J; Chang, SC; da Luz Martins, M; Diekema, DJ; Duse, A; Dzierzanowska, D; Ellis, D; Finquelievich, J; Gibbs, DL; Gould, I; Gur, D; Hoosen, A; Lee, K; Mallatova, N; Mallie, M; Newell, VA; Peng, NG; Petrikos, G; Pfaller, MA; Santiago, A; Trupl, J; VanDen Abeele, AM; Wadula, J; Zaidi, M | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| King, AL; Massey, HD; Stolk, MJ | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Donnelly, JP; Lass-Flörl, C; Rodríguez-Tudela, JL | 1 |
| Gabrielian, A; Hariprasad, SM | 1 |
| Jansen, JP; Janssen, JJ; Lugtenburg, E; O'Sullivan, AK; Span, LF; Stam, WB | 1 |
| Chen, CK; Guilbert, C; Jacobson, MP; Leung, SS; McKerrow, JH; Podust, LM | 1 |
| Bhat G, V; Singla, RK | 1 |
| Arteaga, MA; Gómez, Cde B; Marín, AG; Moreno, AR; Parra, HH; Restrepo, CA; Rodríguez, AZ | 1 |
| Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA | 1 |
| Chen, HT; Cheng, WT; Leaw, SN; Lo, HJ; Wang, AH; Yang, YL | 1 |
| Boel, A; Cartuyvels, R; Magerman, K; Naesens, R; Nys, S; Vijgen, S | 1 |
| Murayama, N; Nakamoto, M; Niwa, T; Shimizu, M; Yamazaki, H | 1 |
| Bouza, E; Escribano, P; Gama, B; Guinea, J; Peláez, T; Recio, S | 1 |
| Lazzaro, C | 1 |
| Kelly, DE; Kelly, SL; Lamb, DC; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG | 1 |
| Biassoni, C; Borghi, E; Cuna, T; Iatta, R; Montagna, MT; Morace, G; Sciota, R | 1 |
| Heeres, J; Lewi, P; Meerpoel, L | 1 |
| Kelly, DE; Kelly, SL; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG | 1 |
| Dag, I; Kiraz, N; Oz, Y | 1 |
| Belda, S; Cremades, R; Lopez, P; Rodriguez, JC; Royo, G; Ruiz-Garcia, M; Soler, L | 1 |
| Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, N; Warrilow, AG; Weig, M | 1 |
| Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, NJ; Warrilow, AG | 1 |
| Magrath, GN; Mason, C; Montero, J; Pulido, JS; Wilson, J | 1 |
| Kim, M; Kim, MN; Lee, K; Lee, MK; Yong, D | 1 |
| Aydin, F; Bayramoglu, G; Guler, NC; Kaklikkaya, N; Tosun, I | 1 |
| Bartlett, KH; Boekhout, T; Geertsen, E; Hagen, F; Illnait-Zaragozi, MT; Klaassen, CH; Meis, JF; Swinne, D | 1 |
| Ausma, J; Bellen, G; Borgers, M; Donders, G; Hinoul, P; Janssens, D; Vaneldere, J; Verguts, L | 1 |
| Chong, PP; Jamal, F; Madhavan, P; Ng, KP | 1 |
| Dranitsaris, G; Khoury, H | 1 |
| Chang, MR; Dias, AL; Gambale, V; Paula, CR; Prates, RA; Ribeiro, MS; Ruiz, Lda S; Silva, EG | 1 |
| Chai, X; Guan, Z; Hu, H; Jiang, Y; Meng, Q; Wu, Q; Yu, S | 1 |
| Ko, KS; Lee, JY; Peck, KR; Song, JH | 1 |
| Abbes, S; Ayadi, A; Ben Jemaa, M; Bouaziz, M; Cheikhrouhou, F; Chelly, H; Hammami, B; Khaled, S; Makni, F; Néji, S; Sellami, A; Sellami, H | 1 |
| Azevedo, AC; Bizerra, FC; Colombo, AL; da Matta, DA; de Almeida, LP; Rosas, R | 1 |
| Boyken, L; Diekema, DJ; Espinel-Ingroff, A; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
| De Rosa, FG; Falcone, M; Ghezzi, MC; Pasero, D; Raponi, G; Russo, A; Toma, L; Venditti, M | 1 |
| Cao, Y; Chai, X; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Xu, J; Yu, S; Zhang, D; Zhang, J; Zou, Y | 1 |
| Cormican, M; Hanahoe, B; Lyons, M; O'Connell, K | 1 |
| Amorim, A; Butler, G; Guida, A; Miranda, IM; Pina-Vaz, C; Rocha, R; Rodrigues, AG; Silva, AP; Silva, R; Synnott, J | 1 |
| Nweze, EI; Ogbonnaya, UL | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zou, Y | 1 |
| He, L; Ji, WB; Liang, YR; Lu, F; Lü, SC; Luo, Y; Shi, XJ; Zhao, ZM | 1 |
| Caggiano, G; Cuna, T; Iatta, R; Montagna, MT | 1 |
| Alves, SH; Azevedo, MI; Botton, SA; Dutra, V; Jesus, FP; Lautert, C; Machado, ML; Mahl, DL; Santurio, JM; Zanette, RA | 1 |
| Brilhante, RS; Caetano, EP; Castelo-Branco, Dde S; Cordeiro, Rde A; de Lima, RA; Fechine, MA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Mourão, CI; Ribeiro, JF; Rocha de Castro E Silva, K; Rocha, FA; Rocha, MF; Sidrim, JJ | 1 |
| Castanheira, M; Hata, K; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA | 1 |
| Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
| Duflos, M; Guillon, R; Le Pape, P; Logé, C; Pagniez, F; Picot, C; Rambaud, C | 1 |
| Kullberg, BJ; Oborska, IT; Oude Lashof, AM; Pappas, PG; Rex, JH; Rothova, A; Ruhnke, M; Schlamm, HT; Sobel, JD; Viscoli, C | 1 |
| Click, J; Gee, SN; Hsu, MY; Rothschild, B; Saavedra, A; Sheth, V | 1 |
| Lingegowda, PB; Tan, AL; Tan, BH; Tan, CK | 1 |
| Mitrokhin, SD; Sokolov, AA | 1 |
| Doroftei, B; Mareş, M; Năstasă, V; Ramona, FM; Stefanache, A | 1 |
| Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K | 1 |
| Bentley, RT; Faissler, D; Sutherland-Smith, J | 1 |
| Damle, B; Varma, MV; Wood, N | 1 |
| Kastelic, J; Kikelj, D; Lah, N; Leban, I | 1 |
| Al-Nawas, B; Karbach, J; Walter, C | 1 |
| Castanheira, M; Diekema, DJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Bassetti, M; Molinari, MP; Mussap, M; Nicco, E; Taramasso, L; Viscoli, C | 1 |
| Cafarchia, C; Figueredo, LA; Iatta, R; Montagna, MT; Otranto, D | 1 |
| Hamoud, S; Hayek, T; Keidar, Z | 1 |
| Bays, D; Cohen, SH; Pappagianis, D; Thompson, GR | 1 |
| Blosser, SJ; Cramer, RA | 1 |
| Geng, RX; Ji, QG; Shi, Y; Zhou, CH; Zhou, XD | 1 |
| Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M | 1 |
| Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J | 1 |
| Dalvie, D; Smith, DA | 1 |
| Lass-Flörl, C | 1 |
| Chang, YC; Dolan, MA; Garraffo, HM; Ghannoum, MA; Kwon-Chung, KJ; Sionov, E | 1 |
| Allizond, V; Banche, G; Cuffini, AM; Fucale, G; Mandras, N; Roana, J; Scalas, D; Tullio, V | 1 |
| Niki, Y; Ohbayashi, H; Shoji, H; Takuma, T; Yamamoto, T; Yoshida, K | 1 |
| Cheng, MF; Hsieh, LY; Liou, CH; Lo, HJ; Lu, DC; Shi, ZY; Tsai, MS; Wang, AH; Wang, LS; Wu, CJ; Yang, YL | 1 |
| Bocanegra, R; Graybill, JR; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Thompson, GR; Wiederhold, NP | 1 |
| Auzinger, G; Borges Sá, M; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Menichetti, F; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sganga, G | 1 |
| Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M | 1 |
| Biswas, J; Gopal, L; Selvakumar, P; Sofia, O | 1 |
| Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC | 1 |
| Chakrabarti, A; Jatana, M; Rudramurthy, SM; Singh, R | 1 |
| Kim, HR; Lee, MK; Yu, N | 1 |
| Cheng, ML; Ha, E; Leibowitz, M | 1 |
| Bader, O; Gross, U; Hull, CM; Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG; Weig, M | 2 |
| Chen, TC; Chen, YC; Chen, YH; Lu, PL | 1 |
| Lacroix, C; Le Pape, P; Miegeville, M; Morio, F; Pagniez, F | 1 |
| Gárate, C; García, P; Guzmán, AM; Labarca, J; León, P; Porte, L | 1 |
| Brilhante, RS; Caetano, ÉP; Camargo, ZP; Castelo-Branco, DS; Cordeiro, RA; Fechine, MA; Lima, RA; Mesquita, JR; Monteiro, AJ; Pereira, JF; Rocha, MF; Sidrim, JJ | 1 |
| Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F | 1 |
| Baez, AA; Bonfietti, LX; Castro e Silva, DM; Martins, MA; Melhem, MS; Pukinskas, SR; Purisco, SU; Szeszs, MW | 1 |
| Cid Lama, A; Crespo Erchiga, V; Fernández Ballesteros, MD; Gomez-Moyano, E; Lova Navarro, M; Vera Casaño, A | 1 |
| Logan, BR; Zhang, MJ | 1 |
| Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L | 1 |
| Aller, AI; Canton, E; Castañón-Olivares, LR; Chowdhary, A; Cordoba, S; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Govender, N; Hagen, F; Illnait-Zaragozi, MT; Johnson, E; Kidd, S; Lass-Flörl, C; Lockhart, SR; Martins, MA; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; Schell, WA; St-Germain, G; Trilles, L; Turnidge, J | 1 |
| Berghs, HAM; Carvalho, LR; Kacew, S; Martins, MA; Melhem, MSC; Mendes, RP; Moris, DV; Pimenta-Rodrigues, MV; Souza, LR; Szeszs, MW | 1 |
| de Souza Bonfim-Mendonça, P; Fiorini, A; Godoy, JS; Nakamura, SS; Pieralisi, N; Shinobu-Mesquita, C; Svidzinski, TI; Yamada, SS | 1 |
| Chen, SC; Chu, YZ; Fan, H; Hu, TS; Hu, ZD; Kong, F; Liao, K; Lu, J; Ni, YX; Shao, HF; Sun, ZY; Wang, H; Xiao, M; Xu, YC; Yan, Y; Zou, GL | 1 |
| Chauhan, NM; Karuppayil, SM; Raut, JS; Shinde, RB | 1 |
| Choi, HJ; Ju, MY; Jung, SI; Kim, SH; Lee, K; Lee, WG; Park, YJ; Shin, JH | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Yu, S; Zhang, D; Zou, Y | 1 |
| Bennett, JE; Myers, TG; Noble, JA; Su, Q; Suffis, SD; Tsai, HF | 1 |
| Estes, LL; Wilson, JW; Zeuli, JD | 1 |
| Hunt, S; Papadopoulos, G; Prasad, M | 1 |
| Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG | 1 |
| Cavaleiro, I; Félix, S; Proença, L; Salema-Oom, M | 1 |
| Gärtner, P; Knoth, H; Petry, T | 1 |
| Furuya, N; Mano, Y; Morishige, H; Oguri, T | 1 |
| Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C | 1 |
| Gude, T; Kulkarni, MM; McGwire, BS; Reddy, N | 1 |
| Aharchi, F; Hoetelmans, RM; Kakuda, TN; Nijs, S; Smedt, GD; Van Solingen-Ristea, R; Vyncke, V; Witek, J | 1 |
| Athanasakis, K; Kyriopoulos, J; Petrakis, I | 1 |
| Hamada, Y; Hirayama, T; Ichibe, Y; Katori, Y; Kuroyama, M; Okuma, R; Takahashi, S | 1 |
| Al-Badriyeh, D; Bajel, A; Grigg, A; Heng, SC; Kirsa, S; Kong, DC; Nation, RL; Seymour, JF; Slavin, MA; Thursky, K | 1 |
| Chowdhary, A; Kathuria, S; Khan, N; Kumar, DA; Meis, JF; Muralidhar, S; Prakash, A; Randhawa, HS; Sharma, C; Singh, PK; Wankhede, S | 1 |
| Arnan, M; Clopés, A; de Sevilla, AF; Duarte, RF; Muñoz, C; Patiño, B; Peralta, T; Sánchez-Ortega, I | 1 |
| Cuenca-Estrella, M; de Lucas, MP; Fusco-Almeida, AM; Lozano, E; Mendes-Giannini, MJ; Mesa-Arango, AC; Scorzoni, L; Zaragoza, O | 1 |
| Chen, HT; Chu, WL; Lin, CC; Lo, HJ; Yang, YL | 1 |
| Coste, A; Eddouzi, J; Ischer, F; Kelly, S; Manai, M; Parker, JE; Sanglard, D; Vale-Silva, LA | 1 |
| Chai, X; Cui, H; Meng, Q; Sun, Q; Wang, B; Wang, N; Wu, Q; Yu, S; Zhao, Q; Zou, Y | 1 |
| Chang, CL; Jang, HC; Jang, MJ; Kim, MN; Kim, SH; Lee, HS; Lee, K; Lee, MK; Lee, WG; Ryang, DW; Shin, JH; Shin, MG; Song, ES; Suh, SP | 1 |
| Inoue, K; Irie, K; Kodama, Y; Matsuo, S; Nishikawa, A; Ozawa, S; Takahashi, M; Tamura, K; Yoshida, M | 1 |
| Arakawa, S; Fujisawa, M; Osawa, K; Shigemura, K; Yoshida, H | 1 |
| Ballot, DE; Bosman, N; Cooper, PA; Nana, T; Ramdin, T | 1 |
| Benjamin, DK; Ericson, J; Manzoni, P | 1 |
| Diekema, DJ; Pfaller, MA; Procop, GW; Rinaldi, MG | 1 |
| Arikan-Akdagli, S; Canton, E; Hazirolan, G; Sahin, S | 1 |
| Alffenaar, JW; Greijdanus, B; Kosterink, JG; Span, LF; Uges, DR; van der Elst, KC; van der Werf, TS; van Hateren, K; Vermeulen, KM | 1 |
| Chen, FP; Chen, XQ; Hu, JD; Huang, XJ; Jin, J; Li, Y; Liang, YM; Liu, T; Shen, Y; Shen, ZX; Wang, JX; Wang, SJ; Wu, DP; Yu, K; Yu, L | 1 |
| Baden, LR; Bolaños-Meade, J; Brown, JM; Chirila, C; Gersten, ID; Graham, J; Horowitz, MH; Kurtzberg, J; Leather, H; Marr, KA; Mauskopf, J; Maziarz, RT; Walsh, TJ; Wingard, JR | 1 |
| Bertz, H; Drognitz, K; Lübbert, M | 1 |
| Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C | 1 |
| Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA | 1 |
| Chen, H; Chen, M; Liao, W; Pan, W; Zhou, J | 1 |
| Adamski, Z; Gil, L; Komarnicki, M; Kubisiak-Michalska, A; Kubisiak-Rzepczyk, H; Mol, A; Reich, A; Zawirska, A | 1 |
| Balci, I; Eksi, F; Gayyurhan, ED | 1 |
| González, GM; González, JG; Hernández-Bello, R; López, LJ; Palma-Nicolás, JP; Treviño-Rangel, Rde J | 1 |
| Dorazilova, Z; Maly, J; Netuka, I; Pirk, J; Szarszoi, O | 1 |
| Bonfietti, LX; Bustamante, B; Canton, E; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Gonzalez, GM; Guarro, J; Lass-Flörl, C; Lockhart, SR; Martin-Mazuelos, E; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; St-Germain, G; Szeszs, MW; Turnidge, J | 1 |
| Kunicka-Styczyńska, A; Maroszyńska, I; Maroszyńska, M; Rajkowska, K | 1 |
| Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Drew, RH; Johnson, MD; Kung, HC; Perfect, JR; Saha-Chaudhuri, P | 1 |
| Åkerborg, Ö; Björkholm, M; Höglund, M; Lundberg, J | 1 |
| Fung, HC; Peksa, GD; Schultz, K | 1 |
| Gong, YX; Ling, F; Liu, L; Wang, GX; Zhu, B | 1 |
| Estevinho, LM; Faria-Ramos, I; Farinha, S; Miranda, IM; Neves-Maia, J; Pina-Vaz, C; Rodrigues, AG; Silva, RM; Tavares, PR | 1 |
| Afsarian, MH; Badali, H; Emami, S; Faramarzi, MA; Hashemi, SM; Irannejad, H; Samadi, N | 1 |
| Che, X; Dong, G; He, X; Jiang, Y; Liu, N; Liu, Y; Miao, Z; Sheng, C; Wang, S; Wang, Y; Wu, S; Yao, J; Zhang, W; Zhang, Y | 1 |
| Boekhout, T; Doroftei, B; Flonta, MM; Kolecka, A; Lupse, M; Man, A; Marangoci, N; Mares, M; Marincu, I; Minea, B; Moraru, RF; Nastasa, V; Pinteala, M; Toma, F | 1 |
| Tam, KY; Wang, C; Yao, H; Zhang, SL | 1 |
| Chang, FY; Chang, PY; Chao, TY; Chen, YC; Dai, MS; Ho, CL; Kan, LP; Kao, WY; Lin, HA; Lin, JC; Lin, TY; Wang, CH; Wang, NC; Wu, YY | 1 |
| Marcella, SW; Sung, AH; Xie, Y | 1 |
| Azie, N; Ghannoum, M; Schmitt-Hoffmann, AH; Viljoen, J | 1 |
| Gamo, T; Inoue, K; Irie, K; Kodama, Y; Matsuo, S; Ozawa, S; Takahashi, M; Tamura, K; Yoshida, M | 1 |
| Cabanillas Stanchi, KM; Döring, M; Ebinger, M; Eikemeier, M; Handgretinger, R; Hartmann, U; Müller, I; Schulz, A; Schwarze, CP | 1 |
| Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Badali, H; Emami, S; Hashemi, SM; Irannejad, H; Shokrzadeh, M | 1 |
| Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R | 1 |
| Fan, S; Li, T; Liang, Y; Liu, X; Xu, H; Zhu, Y | 1 |
| Björkholm, M; Blennow, O; Cederlund, K; Dahlén, T; Kalin, M; Ljungman, P; Nordlander, A | 1 |
| Kelly, DE; Kelly, SL; Lamb, DC; Nes, WD; Parker, JE; Rolley, NJ; Smith, SN; Warrilow, AG | 1 |
| Keniya, MV; Monk, BC; Sagatova, AA; Tyndall, JD; Wilson, RK | 1 |
| Bulanda, M; Jagielski, T; Skóra, M | 1 |
| Back, H; Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kang, S; Kim, HJ; Kim, SH; Kim, YJ; Lee, DG; Lee, EK; Lee, HJ; Min, WS; Park, SH; Yoo, JH | 1 |
| Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kim, HJ; Kim, SH; Kim, YJ; Lee, DG; Lee, HJ; Min, WS; Park, SH; Yoo, JH | 1 |
| Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF | 1 |
| Chan, TS; Gill, H; Hwang, YY; Kwong, YL; Marcella, SW | 1 |
| Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF | 1 |
| Albert, ND; Bellanger, AP; Kontoyiannis, DP; Lewis, RE; Walsh, TJ | 1 |
| Coste, AT; Sanglard, D | 1 |
| Escorial, C; García-Valcárcel, AI; Loureiro, I; Molero, E; Tadeo, JL | 1 |
| Chai, LY; Khoo, AL; Lim, BP; Ong, B; Tan, BH; Tan, G; Tee, C; Teng, M; Zhao, YJ | 1 |
| Fosso, MY; Garneau-Tsodikova, S; Shrestha, SK | 1 |
| Hall, RG; Payne, KD | 1 |
| Alencar, LP; Bandeira, SP; Bandeira, TJ; Brandine, GS; Brilhante, RS; Castelo-Branco, DS; Cordeiro, RA; Guedes, GM; Melo, LM; Moreira, JL; Paiva, MA; Pereira-Neto, WA; Ponte, YB; Rocha, MF; Sales, JA; Sidrim, JJ | 1 |
| Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ | 1 |
| Alem, N; Karabıçak, N | 1 |
| Rosen, T; Stein Gold, LF | 1 |
| Chakrabarti, A; Ghosh, A; Honnavar, P; Pamidi, U; Rastogi, V; Rudramurthy, SM | 1 |
| Antonelli, M; Bassetti, M; Calandra, T; Roberts, JA; Vincent, JL | 1 |
| Arslan, U; Dagi, HT; Findik, D; Senkeles, C | 1 |
| Hancianu, M; Kolecka, A; Marangoci, N; Mares, M; Minea, B; Nastasa, V; Pinteala, M; Rosca, I | 1 |
| Andrade, ZM; Correia, MD; Dalbem, PT; de Oliveira Alves, K; de Oliveira, CF; Heidrich, D; Landell, MF; Pagani, DM; Paulino, GV; Scroferneker, ML; Silva, C; Valente, P | 1 |
| Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK | 1 |
| Barrueta, JA; Bow, EJ; Charbonneau, C; Cordonnier, C; Cornely, OA; Cragin, L; De Salas-Cansado, M; Garcia-Vidal, C; Jarque, I; Marks, DI; Pagliuca, A; Peral, C; Shaul, AJ; Slavin, M; Solano, C; Sorensen, S; Vanness, DJ | 1 |
| Audisio, E; Aversa, F; Bruno, B; Busca, A; Candoni, A; Delia, M; Monaco, F; Mordini, N; Pagano, L; Passera, R; Vacca, A | 1 |
| Abid, M; Aneja, B; Azam, A; Irfan, M; Jairajpuri, MA; Kapil, C; Kavanagh, K; Maguire, R; Manzoor, N; Rizvi, MM | 1 |
| Badali, H; Dannaoui, E; Diba, K; Emami, S; Faeli, L; Fakhim, H; Hashemi, SM; Vaezi, A | 1 |
| Basu, SS; Jarolim, P; Mason, DS; Petrides, A | 1 |
| Caridha, D; Grogl, M; Harris, M; Hickman, M; Hudson, TH; Lang, T; Lecoeur, H; Leed, S; Ngundam, F; O'Neil, M; Parriot, S; Read, L; Sciotti, R; Sena, J | 1 |
| Arthur, I; Baird, R; Bak, N; Blyth, C; Botes, J; Chapman, B; Chen, S; Cheong, E; Cooley, L; George, CR; Goeman, E; Hajkowicz, K; Halliday, C; Heath, CH; Hofmeyr, A; Kalukottege, P; Keighley, C; Kennedy, K; Kesson, A; Kidd, S; Korman, TM; Leung, M; Liu, E; Macesic, N; Marriott, D; McMullan, B; Morrissey, CO; Pendle, S; Robson, J; Slavin, M; Sorrell, TC; Underwood, N; van Hal, S; Weeks, K | 1 |
| Agurto, C; Bustamante, B; Diaz, A; Hidalgo, J; Huaroto, L; Illescas, R; Ramirez, R; Rodriguez, L | 1 |
| Berking, S; Doedens, D; Fiegl, M; Horns, H; Ostermann, H; Rieger, CT | 1 |
| Huang, X; Jin, J; Mao, L; Meng, H; Qian, W; Yang, Q; You, L; Zhu, L | 1 |
| Aragón, B; Cámara, R; Gozalbo, I; Grau, S; Jurado, M; Sanz, J | 2 |
| Faghih-Mirzaei, E; Hoseinpour, K; Javid, N; Khabnadideh, S; Pakshir, K; Rezaei, Z; Sadeghpour, H; Zomorodian, K | 1 |
| Blaich, C; Gehlen, D; Liss, B; Müller, C; Prozeller, D; Streichert, T; Wiesen, MHJ | 1 |
| Badali, H; Chowdhary, A; Dannaoui, E; Fakhim, H; Meis, JF; Prakash, A; Vaezi, A | 1 |
| Chen, L; Dong, W; Dong, Y; Li, Y; Meng, T; Wang, Y; Xie, J; Xing, Y | 1 |
| Bastos, RW; Carneiro, HCS; Carvalho, VSD; Costa, MC; Ferreira, GF; Freitas, GJC; Janbon, G; Magalhães, TFF; Moyrand, F; Oliveira, LVN; Paixão, TA; Rocha, CE; Rocha, KM; Santos, DA | 1 |
| Badali, H; Badiee, P; Boekhout, T; Diba, K; Hossaini Nasab, A; Jafarian, H; Mirhendi, H; Moghadam, AG; Mohammadi, R; Najafzadeh, MJ; Shamsizadeh, A; Soltani, J | 1 |
| Connolly, P; Montejano, R; Spec, A; Wheat, LJ | 1 |
| Ahangarkani, F; Aslani, N; Badali, H; Boekhout, T; Hagen, F; Kolecka, A; Meis, JF; Meyabadi, MF; Shokohi, T | 1 |
| Chang, M; Chang, YC; Khanal Lamichhane, A; Kwon-Chung, KJ; Sionov, E | 1 |
| Chen, CT; Huang, MC; Huang, YJ; Lin, HC; Shen, M | 1 |
| Bartoszewicz, M; Król, J; Nawrot, U | 1 |
| Qiao, M; Qiu, HY; Sun, AN; Tang, L; Tang, XW; Wu, DP; Yang, XF; Zhang, L | 1 |
| Cheng, M; Hao, C; Jiang, X; Su, X; Wei, P; Wu, M; Zhang, X; Zhao, D; Zhao, L; Zhao, S | 1 |
| Lipner, SR; Scher, RK | 1 |
| Keniya, MV; Monk, BC; Ruma, YN; Tyndall, JDA | 1 |
| Keniya, MV; Monk, BC; Sabherwal, M; Sagatova, AA; Tyndall, JDA; Wilson, RK; Woods, MA | 1 |
| Colon, BL; Guy, RK; Kyle, DE; Rice, CA | 1 |
| Covel, J; Fierer, J; Kapoor, M; Okamoto, S; Shaw, KJ; Soltow, QA; Trzoss, M; Viriyakosol, S | 1 |
| Lehrnbecher, T; Schmidt, S; Schubert, R; Tramsen, L | 1 |
| Bandettini, R; Cavanna, C; Esposto, MC; Grancini, A; Lallitto, F; Lo Cascio, G; Mularoni, A; Ossi, C; Prigitano, A; Tejada, M; Tortorano, AM | 1 |
| Chen, L; Li, M; Li, N; Qi, F; Wang, N; Zhu, L | 1 |
| Lewis, JS; Nix, DE; Patterson, TF; Thompson, GR | 1 |
| Barker, KS; Doorley, LA; Nishimoto, AT; Palmer, GE; Rogers, PD; Rybak, JM | 1 |
| Boullié, A; Bretagne, S; Desnos-Ollivier, M; Dromer, F; Gautier, C; Lortholary, O | 1 |
| Flowers, SA; Kelly, DE; Kelly, SL; Nishimoto, AT; Parker, JE; Price, CL; Rogers, PD; Warrilow, AG | 1 |
| Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E | 1 |
| Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
| Al-Hatmi, AM; Arastehfar, A; Bakhtiari, M; Boekhout, T; Daneshnia, F; Fang, W; Groenewald, M; Hagen, F; Liao, W; Pan, W; Sadati, SK; Sharifi-Mehr, H; Zomorodian, K | 1 |
| Emami, S; Ghobadi, E; Hashemi, SM; Saednia, S | 1 |
| Guan, XM; Hu, YL; Li, D; Wang, LH; Weng, LX; Xu, ZH; Yang, DL; Yin, ZX; Zeng, GS; Zhang, YQ | 1 |
| Bordin-Wosk, T; Chun, V; Dhamija, A; Kadakia, A; Lin, AY | 1 |
| Chen, M; Chen, R; Chen, Y; Hu, G; Huang, C; Sun, W; Wang, Z; Zhang, X | 1 |
| Braga, SS | 1 |
| Dastgheib, L; Ghasemi, N; Jowkar, F; Nouraei, H; Pakshir, K; Zomorodian, K | 1 |
| Li, R; Sun, L; Wan, Z; Yu, J | 1 |
| Andreu, D; Cavalcante, CSDP; de Aguiar, FLL; Dos Santos Fontenelle, RO; Falcão, CB; Rádis-Baptista, G | 1 |
| Aala, F; Ahmadi, A; Badali, H; Dannaoui, E; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Mahmoudi, S; Maleki, A; Meis, JF; Rezaie, S | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
| Atanasova, L; Bogáts, G; Büchner, R; Cai, F; Chenthamara, K; Dóczi, I; Druzhinina, IS; Hatvani, L; Homa, M; Kocsubé, S; Kredics, L; Manikandan, P; Mlinaric-Missoni, E; Narendran, V; Revathi, R; Vágvölgyi, C | 1 |
| Elgierari, ETM; Kirkpatrick, LM; Manicke, NE; Ren, GJ; Shi, RZ; Skaggs, CL; Sturmer, LR | 1 |
| Chai, X; Ding, Z; Hao, Y; Jiang, Y; Jin, Y; Ni, T; Wang, T; Xie, F; Yu, S; Zhang, D | 1 |
| Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M | 1 |
| Cheah, R; Dendle, C; Gregory, G; Mohan, B; Tey, A | 1 |
| Pea, F | 1 |
| Gómez-López, A | 1 |
| Chen, R; Cui, Y; Li, S; Shi, Y; Song, Y; Yao, L; Zhao, L; Zhen, Y | 1 |
| Arendrup, MC; Friberg, N; Guinea, J; Kahlmeter, G; Mares, M; Meletiadis, J | 1 |
| Tratrat, C | 1 |
| Burlaga, N; Kaczorek, E; Pacholak, A | 1 |
| Chen, SC; Cornely, OA; Hoenigl, M; Jenks, JD; Thompson, GR | 1 |
| Bai, J; Huang, M; Li, R; Liu, A; Liu, J; Liu, Y; Zhang, T | 1 |
| Gharaghani, M; Taghipour, S; Zarei Mahmoudabadi, A | 1 |
| Al-Obaidi, M; Badali, H; Cañete-Gibas, C; Patterson, HP; Wiederhold, NP | 1 |
| Gao, B; Li, L; Shi, H; Sun, X; Wang, M; Xiong, Y; Zhang, J; Zhao, X | 1 |
| Brüggemann, RJ; Bury, D; Muilwijk, EW; Tissing, WJE; Wolfs, TFW | 1 |
| Bubalo, JS; Gu, TM; Le, H; Lewis, JS | 1 |
| Amanati, A; Badiee, P; Ghasemi, F; Haghpanah, S; Hamzavi, SS; Jafarian, H; Nematolahi, S | 1 |
| Cancino-Prado, G; Elias, TN; Gardam, D; Govender, NP; Guerrero, KD; Healey, KR; Heath, CH; Kordalewska, M; Mikulski, TD; Perlin, DS; Sawh, I; Wilk, A; Williamson, B | 1 |
| Butkiewicz, CD; Schlacks, S; Shubitz, LF; Vishkautsan, P; Worthing, KA | 1 |
| Baidya, ATK; Kumar, A; Kumar, R; Lal, K; Poonia, N; Sahu, S | 1 |
| Behrouz, S; Mohammad-Javadi, M; Soltani Rad, MN; Zarenezhad, E | 1 |
| Chen, L; Chen, W; Li, L | 1 |
| Atas, U; Aydin Ersoy, M; Iltar, U; Salim, O; Turkoglu, EB; Yucel, OK | 1 |
| Adamu Bukari, AR; Chapel, M; Gerstein, AC; Kukurudz, RJ; Sidney, B; Sierhuis, R; Wonitowy, Q | 1 |
| Dong, Y; Liu, Z; Wang, Y; Wang, YF; Xie, J; Yang, Q; Zhang, K | 1 |
| Ajana, MA; Alaqarbeh, M; Alsakhen, N; Bouachrine, M; Bouamrane, S; El-Mernissi, R; Hajji, H; Khaldan, A; Lakhlifi, T; Maghat, H; Sbai, A | 1 |
| Bao, J; Chai, X; Chi, X; Hao, Y; Jin, Y; Liu, J; Liu, Y; Ni, T; Wang, R; Wang, T; Xie, F; Yan, L; Yu, S; Zhang, D | 1 |
| Gong, P; Guo, C; Guo, MB; Hou, Z; Wang, X; Xu, H; Yan, ZZ | 1 |
| Perlovich, GL; Volkova, TV | 1 |
| Colombo, AL; Dieleman, C; Francisco, EC; Hagen, F | 1 |
| Badali, H; Emami, S; Fakhim, H; Ghobadi, E; Hashemi, SM; Hosseini-Khah, Z | 1 |
| Amin Shahidi, M; Badiee, P; Ghasemi, F; Hashemi, J; Jafarian, H; Mohammadi, R; Najafzadeh, MJ; Shokohi, T | 1 |
| Bao, J; Chi, X; Hao, Y; Jin, Y; Li, L; Monk, BC; Ni, T; Wang, R; Wang, T; Xie, F; Yan, L; Yu, S; Zhang, D | 1 |
| Chen, H; Chen, X; Kong, L; Wang, X; Yang, M; Zhou, T; Zhu, P | 1 |
73 review(s) available for triazoles and fluconazole
| Article | Year |
|---|---|
Fungal infections and their management.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine; Triazoles | 1990 |
Testing of organisms for susceptibility to triazoles: is it justified?
Topics: Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles | 1989 |
New antifungal agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Azoles; Echinocandins; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Mycoses; Peptides; Peptides, Cyclic; Triazoles | 1989 |
Azole antifungal agents: emphasis on new triazoles.
Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Triazoles | 1988 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1987 |
Azole antifungal drugs: old and new.
Topics: Animals; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles | 1988 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1988 |
New oral treatments for dermatophytosis.
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Fluconazole; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Triazoles | 1988 |
[Prophylaxis and therapy of fungal infections in oncology].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Incidence; Mycoses; Neoplasms; Triazoles | 1995 |
Worsening of liver function with fluconazole and review of azole antifungal hepatotoxicity.
Topics: Administration, Oral; Alanine Transaminase; Aspartate Aminotransferases; Candidiasis; Chemical and Drug Induced Liver Injury; Female; Fluconazole; Hospitals, Teaching; Humans; Liver Diseases; Liver Function Tests; Middle Aged; Triazoles; Urinary Tract Infections | 1994 |
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Fluconazole; Flucytosine; Humans; Imidazoles; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Transplantation Conditioning; Triazoles | 1996 |
Use of azoles for systemic antifungal therapy.
Topics: Antifungal Agents; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1997 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Dermatitis, Seborrheic; Dermatomycoses; Female; Fluconazole; Humans; Imidazoles; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Morpholines; Onychomycosis; Tinea; Tinea Versicolor; Transplantation; Triazoles | 1995 |
Preventing and treating azole-resistant oropharyngeal candidiasis in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Triazoles | 1998 |
Role of newer azoles in surgical patients.
Topics: Antifungal Agents; Azoles; Candidiasis; Cross Infection; Dose-Response Relationship, Drug; Drug Design; Fluconazole; Humans; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole | 1999 |
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; Fluconazole; Humans; Ketoconazole; Patient Education as Topic; Recurrence; Risk Factors; Teaching Materials; Time Factors; Triazoles | 2000 |
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 2001 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
[Present status and future prospects of azole antifungal agents in Japan].
Topics: Antifungal Agents; Azoles; Cyclodextrins; Drug Design; Fluconazole; Forecasting; Itraconazole; Japan; Miconazole; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
History of the development of azole derivatives.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Pyrimidines; Triazoles; Voriconazole | 2004 |
[New therapeutical options for pulmonary fungal infections in non-neutropenic ICU-patients].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Fungi; Humans; Intensive Care Units; Lipopeptides; Lung Diseases, Fungal; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2003 |
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Combination antifungal therapy: where are we now, and where are we going?
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Antifungal resistance: the clinical front.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Health Status; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome; Triazoles; United States; Voriconazole | 2004 |
Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole.
Topics: Adult; Aged; Antifungal Agents; Child; Female; Fluconazole; Humans; Infant; Male; Middle Aged; Pyrimidines; Saccharomyces; Sepsis; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Pharmacological management of paracoccidioidomycosis.
Topics: Amphotericin B; Central Nervous System Fungal Infections; Drug Resistance; Fluconazole; Follow-Up Studies; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Paracoccidioidomycosis; Pyrimidines; Sulfonamides; Triazoles; Voriconazole | 2005 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Voriconazole: review of a broad spectrum triazole antifungal agent.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2005 |
[Drug-drug interaction of antifungal drugs].
Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole versus amphotericin B in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Treatment of invasive infections due to rare or emerging yeasts and moulds.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Mucormycosis; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2007 |
Candida endophthalmitis: focus on current and future antifungal treatment options.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Echinocandins; Endophthalmitis; Fluconazole; Flucytosine; Humans; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: point.
Topics: Antifungal Agents; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Myelodysplastic Syndromes; Neoplasms; Neutropenia; Risk Assessment; Triazoles | 2008 |
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2008 |
Treatment of invasive candidal infections: systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Antifungals in the ICU.
Topics: Antifungal Agents; Candida; Candidiasis; Critical Illness; Echinocandins; Fluconazole; Humans; Intensive Care Units; Triazoles | 2008 |
Anidulafungin in the treatment of patients with invasive candidiasis.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole | 2008 |
[What's new in the molecular basis of antifungal drug resistance in pathogenic yeasts].
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Fluconazole; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Mutation; Pyrimidines; Saccharomyces cerevisiae Proteins; Sterols; Trans-Activators; Triazoles; Voriconazole | 2008 |
[Oral antifungal agents].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Clinical efficacies of antifungal injections].
Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2008 |
Cerebral aspergillosis: tissue penetration is the key.
Topics: Animals; Antifungal Agents; Fluconazole; Humans; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.
Topics: Amino Acid Substitution; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Pyrimidines; Sequence Analysis, DNA; Sterol 14-Demethylase; Triazoles; Voriconazole | 2010 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Traditional and emerging antifungal therapies.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2010 |
Conazoles.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole | 2010 |
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Why do metabolites circulate?
Topics: Antifungal Agents; Dipeptidyl-Peptidase IV Inhibitors; Fluconazole; Glucuronides; Humans; Liver; Metabolome; Pharmaceutical Preparations; Pyrazines; Sitagliptin Phosphate; Triazoles | 2012 |
Triazole antifungal agents in invasive fungal infections: a comparative review.
Topics: Antifungal Agents; Fluconazole; Fungi; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Bibliographical investigation (domestic and overseas) on the treatment of endogenous Candida endophthalmitis over an 11-year period.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Female; Fluconazole; Humans; Infant; Japan; Male; MEDLINE; Middle Aged; Pyrimidines; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole; Young Adult | 2013 |
Background changing patterns of neonatal fungal sepsis in a developing country.
Topics: Antifungal Agents; Birth Weight; Candida; Candidemia; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Humans; Incidence; Infant, Newborn; Male; Microbial Sensitivity Tests; Pyrimidines; Risk Factors; Socioeconomic Factors; South Africa; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Echinocandins; Fluconazole; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Neonatology; Pyrimidines; Triazoles; Voriconazole | 2013 |
Rhodotorula minuta as onychomycosis agent in a Chinese patient: first report and literature review.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Asian People; China; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Rhodotorula; Triazoles; Voriconazole | 2014 |
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Incidence; Mycoses; Pyrimidines; Risk Factors; Time Factors; Triazoles; Voriconazole | 2014 |
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2014 |
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
Topics: Adult; Antifungal Agents; Aspergillus; Candida; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Mycoses; Singapore; Survival Analysis; Triazoles; Voriconazole | 2016 |
Dosing of antifungal agents in obese people.
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Obesity; Pyridines; Triazoles | 2016 |
Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Disease Management; Fluconazole; Humans; Intensive Care Units; Triazoles | 2016 |
Onychomycosis: Treatment and prevention of recurrence.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles | 2019 |
Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis.
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Drug Discovery; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Triazoles | 2019 |
Therapeutic tools for oral candidiasis: Current and new antifungal drugs.
Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis, Oral; Caspofungin; Clotrimazole; Databases, Factual; Drug Interactions; Echinocandins; Fluconazole; Humans; Miconazole; Nitriles; Nystatin; Pyridines; Triazoles | 2019 |
Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies.
Topics: Animals; Antifungal Agents; Candida; Candidiasis; Drug Design; Drug Discovery; Fluconazole; Fungi; Humans; Models, Molecular; Mycoses; Triazoles | 2019 |
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Antimicrobial Stewardship; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis, Invasive; Echinocandins; Fluconazole; Flucytosine; Humans; Species Specificity; Triazoles; Voriconazole | 2020 |
Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation.
Topics: Antifungal Agents; Drug Monitoring; Echinocandins; Fluconazole; Humans; Mycoses; Nitriles; Polyenes; Practice Guidelines as Topic; Pyridines; Triazoles | 2020 |
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Triazoles; Voriconazole | 2020 |
1,2,4-Triazole: A Privileged Scaffold for the Development of Potent Antifungal Agents - A Brief Review.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis, Invasive; Drug Design; Fluconazole; Humans; Itraconazole; Structure-Activity Relationship; Treatment Outcome; Triazoles | 2020 |
Breakthrough invasive fungal infections: Who is at risk?
Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillus; Candida; Central Venous Catheters; Echinocandins; Fluconazole; Fusarium; Genetic Predisposition to Disease; Hematologic Neoplasms; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Mucorales; Mycoses; Neutropenia; Opportunistic Infections; Organ Transplantation; Penicillium; Risk Factors; Triazoles | 2020 |
Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Female; Fluconazole; Genes, Fungal; Humans; Immunosuppression Therapy; Microbial Sensitivity Tests; Mycoses; Nitriles; Phylogeny; Pneumonia; Pyridines; Saccharomycetales; Triazoles | 2021 |
Clinical Pharmacokinetics of Triazoles in Pediatric Patients.
Topics: Adult; Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Mycoses; Triazoles; Voriconazole | 2021 |
38 trial(s) available for triazoles and fluconazole
| Article | Year |
|---|---|
Single dose oral fluconazole vs intravaginal terconazole in treatment of Candida vaginitis. Comparison and pilot study.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; Humans; Middle Aged; Pilot Projects; Placebos; Suppositories; Tablets; Time Factors; Triazoles | 1992 |
A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Report of an international multicentre trial.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Fluconazole; Humans; Imidazoles; Multicenter Studies as Topic; Triazoles | 1989 |
[Clinical study of fluconazole on deep-seated fungal infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Clinical Trials as Topic; Cryptococcosis; Drug Tolerance; Female; Fluconazole; Humans; Japan; Male; Middle Aged; Multicenter Studies as Topic; Mycoses; Triazoles | 1989 |
Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives.
Topics: Adult; Antifungal Agents; Apolipoproteins; Body Weight; Contraceptives, Oral, Hormonal; Female; Fluconazole; Glucose Tolerance Test; Gonadal Steroid Hormones; Hormones; Humans; Hydrocortisone; Lipids; Lipoproteins; Sex Hormone-Binding Globulin; Triazoles | 1989 |
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidiasis, Oral; Clinical Trials as Topic; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; Humans; Ketoconazole; Male; Middle Aged; Oropharynx; Pharyngeal Diseases; Prospective Studies; Recurrence; Triazoles | 1989 |
A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Clinical Trials as Topic; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles | 1988 |
Fluconazole and testosterone: in vivo and in vitro studies.
Topics: Adult; Analysis of Variance; Animals; Antifungal Agents; Cells, Cultured; Double-Blind Method; Fluconazole; Humans; Ketoconazole; Leydig Cells; Male; Rats; Testosterone; Triazoles | 1988 |
Treatment of vaginal candidiasis with a single oral dose of fluconazole. Multicentre Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Candida albicans; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Female; Fluconazole; Humans; Middle Aged; Triazoles | 1988 |
Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Antigens, Fungal; Clinical Trials as Topic; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Male; Triazoles | 1988 |
Fluconazole in the management of patients with chronic mucocutaneous candidosis.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topic; Fluconazole; Humans; Triazoles | 1988 |
Single-dose oral fluconazole in the treatment of vaginal candidosis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Fluconazole; Humans; Ketoconazole; Triazoles | 1988 |
A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Fluconazole; Humans; Ketoconazole; Middle Aged; Multicenter Studies as Topic; Random Allocation; Recurrence; Triazoles | 1988 |
Fluconazole in the treatment of Candida-associated denture stomatitis.
Topics: Aged; Candidiasis, Oral; Clinical Trials as Topic; Double-Blind Method; Female; Fluconazole; Humans; Male; Middle Aged; Stomatitis; Stomatitis, Denture; Triazoles; Yeasts | 1988 |
Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pilot Projects; Treatment Outcome; Triazoles | 1998 |
Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Colony Count, Microbial; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Microbial Sensitivity Tests; Prospective Studies; Treatment Outcome; Triazoles | 1999 |
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Consumer Product Safety; Double-Blind Method; Esophageal Diseases; Female; Fluconazole; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2001 |
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.
Topics: Antifungal Agents; Candida; Candidiasis; Data Interpretation, Statistical; Drug Resistance, Fungal; Endpoint Determination; Fluconazole; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2006 |
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Candidiasis, Oral; Double-Blind Method; Ethnicity; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pharyngeal Diseases; Probability; Treatment Outcome; Triazoles | 2006 |
Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-Ibuprofen.
Topics: Adult; Analgesics, Non-Narcotic; Antifungal Agents; Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fluconazole; Half-Life; Humans; Ibuprofen; Male; Pyrimidines; Therapeutic Equivalency; Triazoles; Voriconazole | 2006 |
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Esophageal Diseases; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Probability; Severity of Illness Index; Treatment Failure; Treatment Outcome; Triazoles | 2007 |
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Female; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mycoses; Opportunistic Infections; Risk Factors; Triazoles | 2007 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fluconazole; Humans; Itraconazole; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Opportunistic Infections; Single-Blind Method; Treatment Outcome; Triazoles | 2007 |
Voriconazole and fluconazole increase the exposure to oral diazepam.
Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cognition; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diazepam; Drug Interactions; Enzyme Inhibitors; Female; Fluconazole; Genotype; Half-Life; Humans; Hypnotics and Sedatives; Male; Mixed Function Oxygenases; Nordazepam; Pyrimidines; Triazoles; Voriconazole; Wakefulness | 2007 |
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl.
Topics: Administration, Oral; Analgesics, Opioid; Antifungal Agents; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Inhibitors; Female; Fentanyl; Fluconazole; Humans; Injections, Intravenous; Male; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2008 |
Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Triazoles; Young Adult | 2009 |
Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands.
Topics: Adult; Double-Blind Method; Female; Fluconazole; Graft vs Host Disease; Humans; Male; Models, Economic; Netherlands; Quality-Adjusted Life Years; Triazoles | 2010 |
[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Drug Costs; Equipment and Supplies; Fluconazole; Follow-Up Studies; Hospital Costs; Humans; Immunocompromised Host; Infusions, Intravenous; Italy; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Nursing; Treatment Outcome; Triazoles | 2010 |
Ocular manifestations of candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidemia; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Incidence; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Triazoles; Voriconazole; Young Adult | 2011 |
[Modern antifungals in therapy of nosocomial mycosis in oncologic patients].
Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Cross Infection; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Neoplasms; Pyrimidines; Triazoles; Voriconazole | 2011 |
Pharmacokinetics of voriconazole administered concomitantly with fluconazole and population-based simulation for sequential use.
Topics: Adult; Body Mass Index; Cross-Over Studies; Fluconazole; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2011 |
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Pharmacokinetics and short-term safety of etravirine in combination with fluconazole or voriconazole in HIV-negative volunteers.
Topics: Adolescent; Adult; Anti-HIV Agents; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Fluconazole; Genotype; HIV Infections; Humans; Male; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Triazoles; Voriconazole; Young Adult | 2013 |
Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles | 2013 |
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
Topics: Antifungal Agents; Case-Control Studies; Cohort Studies; Cost-Benefit Analysis; Decision Support Techniques; Double-Blind Method; Fluconazole; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2013 |
No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.
Topics: Adult; Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Laboratory Techniques; Female; Fluconazole; Fungemia; Germany; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles; Young Adult | 2014 |
Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluconazole; Hematologic Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mycoses; Retrospective Studies; Treatment Outcome; Triazoles; United States | 2014 |
A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Double-Blind Method; Esophageal Diseases; Female; Fluconazole; Humans; Male; Nitriles; Pyridines; Triazoles | 2015 |
A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Case-Control Studies; China; Drug-Related Side Effects and Adverse Reactions; Female; Fluconazole; Humans; Middle Aged; Prospective Studies; Suppositories; Treatment Outcome; Triazoles; Young Adult | 2015 |
632 other study(ies) available for triazoles and fluconazole
| Article | Year |
|---|---|
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles | 1992 |
Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.
Topics: Adult; Aged; Amphotericin B; Animals; Antifungal Agents; Child, Preschool; Disease Models, Animal; Female; Fluconazole; Humans; Immunocompromised Host; Male; Mice; Miconazole; Middle Aged; Mycoses; Triazoles; Trichosporon | 1992 |
Saperconazole: in vitro and in vivo anticandidal activity.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Drug Synergism; Fluconazole; Microbial Sensitivity Tests; Species Specificity; Triazoles | 1992 |
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation, Preclinical; Fluconazole; Injections, Intravenous; Ketoconazole; Kidney; Male; Mice; Triazoles | 1992 |
Treatment of experimental cryptococcosis with SCH 39304 and fluconazole.
Topics: Animals; Antifungal Agents; Brain; Cryptococcosis; Female; Fluconazole; Lung; Male; Rats; Rats, Inbred Strains; Triazoles | 1991 |
SCH 39304 in the treatment of acute or established murine pulmonary blastomycosis.
Topics: Animals; Antifungal Agents; Blastomycosis; Fluconazole; Ketoconazole; Lung Diseases; Mice; Mice, Inbred BALB C; Triazoles | 1991 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Disease Models, Animal; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluconazole; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Meningitis; Mice; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Triazoles | 1990 |
Treatment of murine coccidioidal meningitis with SCH39304.
Topics: Animals; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fluconazole; Itraconazole; Ketoconazole; Meningitis; Mice; Mice, Inbred BALB C; Triazoles | 1990 |
The pharmacokinetics of BAY R3783 and its efficacy in the treatment of experimental cryptococcal meningitis.
Topics: Animals; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Itraconazole; Ketoconazole; Meningitis; Rabbits; Triazoles | 1990 |
Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Fluconazole; Lung Diseases, Fungal; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles | 1990 |
In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis, Vulvovaginal; Cryptococcosis; Female; Fluconazole; Guinea Pigs; Male; Mice; Mice, Inbred Strains; Rats; Rats, Inbred Strains; Tinea; Triazoles | 1990 |
SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits.
Topics: Agranulocytosis; Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Female; Fluconazole; Immunosuppression Therapy; Rabbits; Triazoles | 1990 |
Comparison of fluconazole and SDZ89-485 for therapy of experimental murine coccidioidomycosis.
Topics: Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Female; Fluconazole; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Triazoles | 1990 |
In-vitro activity of SCH39304 in comparison with amphotericin B and fluconazole.
Topics: Amphotericin B; Culture Media; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Triazoles | 1990 |
In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.
Topics: Amphotericin B; Animals; Antifungal Agents; Female; Fluconazole; Histoplasma; Histoplasmosis; Leukopenia; Mice; Microbial Sensitivity Tests; Triazoles | 1990 |
Treatment of murine pulmonary blastomycosis with SCH 39304, a new triazole antifungal agent.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomycosis; Fluconazole; Lung; Lung Diseases, Fungal; Male; Mice; Mice, Inbred BALB C; Triazoles | 1990 |
Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis.
Topics: Animals; Antifungal Agents; Coccidioidomycosis; Fluconazole; Male; Mice; Triazoles | 1990 |
Fluconazole for cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Meningitis; Triazoles | 1989 |
Oral fluconazole for treatment of disseminated fungal infection.
Topics: Administration, Oral; Candidiasis; Child; Female; Fluconazole; Humans; Triazoles | 1989 |
Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Pilot Projects; Triazoles | 1989 |
Pharmacokinetics of oral fluconazole in autologous bone marrow transplantation recipients given TBI and high-dose melphalan.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Bone Marrow Transplantation; Drug Administration Schedule; Female; Fluconazole; Humans; Male; Melphalan; Middle Aged; Mycoses; Transplantation, Autologous; Triazoles; Whole-Body Irradiation | 1989 |
[AIDS: bad prognosis in candidiasis. Cryptococcosis in brain involvement is usually fatal--experiences with a new therapeutic drug].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Meningitis; Opportunistic Infections; Prognosis; Triazoles | 1989 |
Treatment of systemic yeast infection with fluconazole.
Topics: Candidiasis; Fluconazole; Humans; Triazoles | 1989 |
[In vitro activity of fluconazole, a novel bistriazole antifungal agent].
Topics: Animals; Antifungal Agents; Ascitic Fluid; Aspergillus; Candida albicans; Culture Media; Dose-Response Relationship, Drug; Fluconazole; Humans; Hydrogen-Ion Concentration; Ketoconazole; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Triazoles; Yeasts | 1989 |
[Clinical evaluation of fluconazole in the case of deep mycosis associated with leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Injections, Intravenous; Leukemia; Lung Diseases, Fungal; Male; Middle Aged; Triazoles | 1989 |
[The clinical study of fluconazole against pulmonary mycosis. Effects of fluconazole on pulmonary cryptococcosis and aspergillosis, and its pharmacokinetics in patients].
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Cryptococcosis; Drug Evaluation; Fluconazole; Half-Life; Humans; Lung Diseases, Fungal; Male; Middle Aged; Triazoles | 1989 |
[Clinical efficacy of fluconazole in the patient with pulmonary mycosis].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antifungal Agents; Aspergillosis; Cryptococcosis; Drug Evaluation; Female; Fever; Fluconazole; Humans; Infusions, Intravenous; Lung Diseases, Fungal; Male; Middle Aged; Nausea; Triazoles | 1989 |
[A clinical evaluation of fluconazole in the treatment of deep mycosis].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Fungi; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Triazoles | 1989 |
[Clinical evaluation of fluconazole in patients with mycotic infection].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Candidiasis; Candidiasis, Oral; Drug Evaluation; Female; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Sepsis; Tissue Distribution; Triazoles | 1989 |
[Experience of fluconazole in pediatric patients].
Topics: Administration, Oral; Adolescent; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Infant; Male; Mycoses; Risk Factors; Triazoles | 1989 |
[Pharmacokinetic evaluation of fluconazole in healthy volunteers].
Topics: Administration, Oral; Adult; Antifungal Agents; Blood Chemical Analysis; Drug Tolerance; Fluconazole; Half-Life; Humans; Injections, Intravenous; Male; Reference Values; Triazoles | 1989 |
[Clinical efficacy of fluconazole in urinary tract fungal infections].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Infusions, Intravenous; Male; Middle Aged; Triazoles; Urinary Tract Infections | 1989 |
[Clinical evaluation of fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Ambulatory Care; Antifungal Agents; Antigens, Fungal; Candidiasis; Child; Cryptococcosis; Cryptococcus neoformans; Drug Evaluation; Esophagitis; Female; Fluconazole; Humans; Male; Meningitis; Middle Aged; Mycoses; Renal Dialysis; Triazoles | 1989 |
[A clinical study of fluconazole in pulmonary aspergillosis].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Lung Diseases, Fungal; Male; Middle Aged; Radiography, Thoracic; Sputum; Triazoles | 1989 |
[A clinical evaluation of injectable fluconazole in the treatment of deep mycosis associated with hematological malignancy].
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Injections, Intravenous; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Triazoles | 1989 |
[Fluconazole treatment of systemic mycoses].
Topics: Adolescent; Adult; Aged; Anorexia; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance; Endophthalmitis; Female; Fluconazole; Humans; Leukopenia; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Triazoles | 1989 |
[Recent antifungal agents].
Topics: Allylamine; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Morpholines; Mycoses; Triazoles | 1989 |
Interaction of fluconazole and cyclosporine.
Topics: Antifungal Agents; Cyclosporins; Drug Interactions; Female; Fluconazole; Humans; Middle Aged; Triazoles | 1989 |
[AIDS fungus infections. Fluconazole--a new preparation in development].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Opportunistic Infections; Triazoles | 1989 |
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Half-Life; Itraconazole; Ketoconazole; Male; Mice; Neutropenia; Triazoles | 1989 |
Treatment of candidal leukoplakia with fluconazole.
Topics: Antifungal Agents; Candidiasis, Oral; Cheilitis; Fluconazole; Humans; Male; Middle Aged; Triazoles | 1989 |
Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent.
Topics: Adult; Antifungal Agents; Candidiasis; Dialysis Solutions; Female; Fluconazole; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Triazoles | 1989 |
Pharmacokinetics and tissue penetration of fluconazole in rabbits.
Topics: Animals; Antifungal Agents; Chromatography, High Pressure Liquid; Female; Fluconazole; Rabbits; Triazoles | 1989 |
Fluconazole and phenytoin: a predictable interaction.
Topics: Antifungal Agents; Drug Interactions; Fluconazole; Humans; Middle Aged; Phenytoin; Triazoles | 1989 |
Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Humans; Male; Meningitis; Prostatic Diseases; Recurrence; Triazoles; Urine | 1989 |
[International symposium: Fluconazole in fungal infections. 20-21 January 1989, Berlin. Abstracts].
Topics: Antifungal Agents; Fluconazole; Humans; Mycoses; Triazoles | 1989 |
A comparison of fluconazole and ketoconazole in the treatment of rat palatal candidosis.
Topics: Animals; Antifungal Agents; Candidiasis, Oral; Epithelium; Fluconazole; Image Processing, Computer-Assisted; Ketoconazole; Male; Microcomputers; Palate; Rats; Rats, Inbred Strains; Triazoles | 1989 |
A comparative study of the effects of ketoconazole and fluconazole on 17-beta estradiol production by rat ovaries in vitro.
Topics: Animals; Antifungal Agents; Estradiol; Female; Fluconazole; In Vitro Techniques; Ketoconazole; Ovary; Radioimmunoassay; Rats; Rats, Inbred Strains; Triazoles | 1989 |
Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection.
Topics: Chromatography, Gas; Fluconazole; Humans; Indicators and Reagents; Triazoles | 1989 |
Treatment of vaginal candidosis with fluconazole.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Follow-Up Studies; Humans; Triazoles | 1989 |
New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Fluconazole; Gastrointestinal Diseases; Humans; Itraconazole; Ketoconazole; Triazoles | 1989 |
Cutaneous cryptococcosis: treatment with oral fluconazole.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Cryptococcosis; Dermatomycoses; Fluconazole; Humans; Male; Triazoles | 1989 |
Sputum levels of fluconazole in humans.
Topics: Aged; Antifungal Agents; Bronchiectasis; Female; Fluconazole; Humans; Male; Middle Aged; Sputum; Triazoles | 1989 |
Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Fluconazole; Guinea Pigs; Itraconazole; Ketoconazole; Male; Mucormycosis; Rhizopus; Triazoles | 1989 |
Fluconazole treatment of cryptococcosis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Triazoles | 1989 |
Fluconazole treatment of Candida glabrata peritonitis.
Topics: Adult; Candida; Candidiasis; Female; Fluconazole; Humans; Peritonitis; Triazoles | 1989 |
Fluconazole (UK-49,858) treatment of candidiasis in normal and diabetic rats.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Diabetes Mellitus, Experimental; Fluconazole; Male; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Saccharomyces cerevisiae; Triazoles | 1989 |
In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy.
Topics: Antifungal Agents; Buffers; Candida; Candida albicans; Culture Media; Fluconazole; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Temperature; Time Factors; Triazoles | 1989 |
Efficacy of SCH39304 in murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Female; Fluconazole; Lung; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Spleen; Triazoles | 1989 |
Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Meningitis; Microbial Sensitivity Tests; Rabbits; Triazoles | 1989 |
Fluconazole in renal candidosis.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Kidney Diseases; Male; Middle Aged; Triazoles | 1989 |
Fluconazole and candidosis.
Topics: Adult; Antifungal Agents; Candidiasis; Fluconazole; Heart Transplantation; Humans; Immune Tolerance; Lung Transplantation; Male; Mediastinal Diseases; Triazoles | 1989 |
Hypokalaemia in patients with acute myeloid leukaemia after treatment with fluconazole.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Humans; Hypokalemia; Leukemia, Myeloid, Acute; Triazoles | 1989 |
Jaundice in HIV positive haemophiliac.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Fluconazole; Hemophilia A; HIV Seropositivity; Humans; Jaundice; Liver Function Tests; Male; Triazoles | 1989 |
Fluconazole versus ketoconazole in oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Female; Fluconazole; Humans; Ketoconazole; Male; Pharyngeal Diseases; Triazoles | 1989 |
Interaction of fluconazole with cyclosporin.
Topics: Creatinine; Cryptococcosis; Cyclosporins; Drug Interactions; Fluconazole; Humans; Kidney; Kidney Transplantation; Leg Dermatoses; Male; Middle Aged; Triazoles | 1989 |
Interaction of fluconazole with cyclosporin.
Topics: Antifungal Agents; Cyclosporins; Drug Interactions; Fluconazole; Humans; Triazoles | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles | 1987 |
Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system.
Topics: Animals; Central Nervous System Diseases; Cryptococcosis; Fluconazole; Macaca mulatta; Male; Triazoles | 1988 |
Comparison of two azole antifungal drugs, ketoconazole, and fluconazole, as modifiers of rat hepatic monooxygenase activity.
Topics: Animals; Antifungal Agents; Fluconazole; Ketoconazole; Kinetics; Male; Microsomes, Liver; Mixed Function Oxygenases; Rats; Rats, Inbred Strains; Substrate Specificity; Testosterone; Triazoles | 1988 |
Toxicity of intravitreal injection of fluconazole in the rabbit.
Topics: Animals; Antifungal Agents; Electroretinography; Eye; Fluconazole; Microscopy; Ophthalmoscopy; Rabbits; Triazoles; Vitreous Body | 1987 |
Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Male; Meningitis; Triazoles | 1988 |
Comparison of fluconazole and amphotericin B in treating histoplasmosis in immunosuppressed mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Cyclophosphamide; Female; Fluconazole; Histoplasmosis; Hydrocortisone; Immunosuppression Therapy; Mice; Mice, Inbred AKR; Triazoles | 1987 |
Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; Ketoconazole; Rabbits; Triazoles | 1988 |
Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis.
Topics: Adult; Aged; Antifungal Agents; Child; Coccidioidomycosis; Female; Fluconazole; Half-Life; Humans; Male; Meningitis; Middle Aged; Triazoles | 1988 |
In vitro effects of fluconazole (UK-49,858) and ketoconazole on mouse lymphocyte proliferation and on Candida blastospore destruction by human polymorphonuclear leukocytes.
Topics: Animals; Antifungal Agents; Candida albicans; Cytotoxicity, Immunologic; Fluconazole; Humans; In Vitro Techniques; Ketoconazole; Lymphocyte Activation; Mice; Mice, Inbred Strains; Neutrophils; Spores, Fungal; Triazoles | 1988 |
Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients.
Topics: Adult; Aged; Candida albicans; Candidiasis; Candidiasis, Oral; Female; Fluconazole; HIV Seropositivity; Humans; Male; Middle Aged; Pharyngeal Diseases; Time Factors; Triazoles | 1988 |
Primary cutaneous phaeohyphomycosis. Report of three cases.
Topics: Adult; Aged; Aged, 80 and over; Dermatomycoses; Female; Fluconazole; Humans; Immune Tolerance; Ketoconazole; Male; Triazoles | 1988 |
Fluconazole penetration into cerebrospinal fluid in humans.
Topics: Fluconazole; Half-Life; Humans; Infusions, Intravenous; Meningitis; Triazoles | 1988 |
Treatment of two cases of cryptococcal meningitis with fluconazole.
Topics: Adolescent; Amphotericin B; Cryptococcosis; Cryptococcus; Female; Fluconazole; Humans; Male; Meningitis; Middle Aged; Triazoles | 1988 |
Fluconazole in the treatment of candidal prosthetic valve endocarditis.
Topics: Adult; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prosthesis; Humans; Mitral Valve; Triazoles | 1988 |
[New antiparasitic drugs].
Topics: Amebicides; Anthelmintics; Antifungal Agents; Antimalarials; Artemisinins; Fluconazole; Humans; Itraconazole; Ketoconazole; Mefloquine; Phenanthrenes; Quinolines; Sesquiterpenes; Triazoles | 1988 |
Use of fluconazole in a patient with documented malabsorption of ketoconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Female; Fluconazole; Humans; Intestinal Absorption; Ketoconazole; Triazoles | 1988 |
Treatment of coccidioidal meningitis with fluconazole.
Topics: Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Male; Meningitis; Middle Aged; Triazoles | 1988 |
Determination of fluconazole in biological fluids by capillary column gas chromatography with a nitrogen detector.
Topics: Antifungal Agents; Chromatography, Gas; Dialysis; Fluconazole; Humans; Nitrogen; Triazoles | 1988 |
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Male; Meningitis; Middle Aged; Pneumonia; Triazoles | 1988 |
Improved method for azole antifungal susceptibility testing.
Topics: Antifungal Agents; Azoles; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Triazoles | 1988 |
Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes.
Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Cholesterol; Chromatography, Gas; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Fluconazole; Gas Chromatography-Mass Spectrometry; Itraconazole; Ketoconazole; Leishmania; Leishmania braziliensis; Leishmania donovani; Leishmania mexicana; Leishmania tropica; Sterols; Triazoles | 1988 |
Effects of two oral antimycotics, ketoconazole and fluconazole, upon steroidogenesis in rat adrenal cells in vitro.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Antifungal Agents; Cells, Cultured; Dose-Response Relationship, Drug; Fluconazole; Ketoconazole; Male; Pregnenolone; Rats; Rats, Inbred Strains; Steroids; Triazoles | 1988 |
Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections.
Topics: Antifungal Agents; Candida albicans; Cell Adhesion; Clotrimazole; Female; Fluconazole; Humans; Imidazoles; In Vitro Techniques; Ketoconazole; Neutrophils; Phagocytosis; Triazoles; Vagina | 1988 |
Activity of triazole derivatives against Pityrosporum orbiculare in vitro and in vivo.
Topics: Animals; Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Rabbits; Structure-Activity Relationship; Tinea Versicolor; Triazoles | 1988 |
Design and evaluation of a systemically active agent, fluconazole.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Design; Female; Fluconazole; Humans; Mice; Molecular Structure; Structure-Activity Relationship; Triazoles | 1988 |
Steady state parenteral kinetics of fluconazole in man.
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Fluconazole; Humans; Infusions, Intravenous; Male; Triazoles | 1988 |
Fluconazole for the treatment of fungal diseases in immunosuppressed patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Immunosuppression Therapy; Kidney Transplantation; Meningitis; Triazoles | 1988 |
The new generation of antifungal drugs.
Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Triazoles | 1988 |
Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Esophageal Diseases; Esophagoscopy; Female; Fluconazole; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Scleroderma, Systemic; Triazoles | 1988 |
Fluconazole resistance in Candida glabrata.
Topics: Antifungal Agents; Bile; Candida; Candidiasis; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Female; Fluconazole; Humans; Middle Aged; Triazoles; Urine | 1988 |
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Dermatomycoses; Female; Fluconazole; Guinea Pigs; Immunosuppression Therapy; Ketoconazole; Mice; Rats; Rats, Inbred Strains; Tinea; Triazoles | 1985 |
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.
Topics: Animals; Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Meningitis, Haemophilus; Rabbits; Triazoles | 1985 |
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Female; Fluconazole; Immune Tolerance; Intestinal Diseases; Ketoconazole; Kinetics; Mice; Triazoles | 1985 |
Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans.
Topics: Adolescent; Adult; Animals; Antifungal Agents; Autoradiography; Biological Availability; Blood Proteins; Dogs; Female; Fluconazole; Humans; Kinetics; Male; Mice; Middle Aged; Protein Binding; Rats; Species Specificity; Tissue Distribution; Triazoles | 1985 |
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immunity; Itraconazole; Ketoconazole; Meningitis; Pyelonephritis; Rabbits; Triazoles | 1986 |
Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum.
Topics: Amphotericin B; Animals; Fluconazole; Histoplasma; Histoplasmosis; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Triazoles | 1986 |
Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858).
Topics: Amphotericin B; Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Fluconazole; Ketoconazole; Male; Meningitis; Mice; Mice, Inbred ICR; Triazoles | 1986 |
Azole resistance in Candida albicans.
Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Disease Models, Animal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Guinea Pigs; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Mice; Miconazole; Rats; Rats, Inbred Strains; Triazoles | 1986 |
Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomycosis; Fluconazole; Male; Mice; Mice, Inbred BALB C; Triazoles | 1986 |
Treatment of cryptococcal meningitis in mice with fluconazole.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Fluconazole; Ketoconazole; Kinetics; Meningitis; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Rats; Rats, Inbred Strains; Triazoles | 1986 |
Treatment of murine histoplasmosis with UK 49,858 (fluconazole).
Topics: Animals; Antifungal Agents; Female; Fluconazole; Histoplasmosis; Ketoconazole; Lung Diseases, Fungal; Male; Mice; Mice, Inbred ICR; Mice, Nude; Triazoles | 1986 |
Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro.
Topics: Adenosine Triphosphate; Antifungal Agents; Arthrodermataceae; Aspergillus; Candida albicans; Fluconazole; Microbial Sensitivity Tests; Spheroplasts; Triazoles | 1986 |
Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo.
Topics: Animals; Antifungal Agents; Buffers; Candida albicans; Culture Media; Fluconazole; Fungal Proteins; Hydrogen-Ion Concentration; Ketoconazole; Male; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Triazoles | 1986 |
Gas chromatographic method for the determination of fluconazole, a novel antifungal agent, in human plasma and urine.
Topics: Antifungal Agents; Chromatography, Gas; Fluconazole; Humans; Triazoles | 1986 |
Cryptococcal meningitis and fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Male; Meningitis; Triazoles | 1987 |
Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye; Fluconazole; Itraconazole; Ketoconazole; Kinetics; Male; Rabbits; Tissue Distribution; Triazoles | 1987 |
Action of fluconazole (UK-49,858) in relation to other systemic antifungal azoles.
Topics: Antifungal Agents; Candida; Candida albicans; Fluconazole; Ketoconazole; Miconazole; Triazoles | 1987 |
Fungistatic and fungicidal effects of amphotericin B, ketoconazole and fluconazole (UK 49,858) against histoplasma capsulatum in vitro and in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Culture Techniques; Fluconazole; Histoplasma; Histoplasmosis; Ketoconazole; Male; Mice; Triazoles | 1987 |
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Brain Diseases; Cryptococcosis; Female; Fluconazole; Ketoconazole; Lung Diseases, Fungal; Mice; Opportunistic Infections; Triazoles | 1987 |
Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells.
Topics: Animals; Antifungal Agents; Cell Survival; Centrifugation; Fluconazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Luminescent Measurements; Luminol; Mice; Mice, Inbred BALB C; Naphthalenes; Phagocytes; Rabbits; Rifampin; Spleen; Terbinafine; Triazoles | 1987 |
Resistance to azole drugs in Neurospora crassa.
Topics: Antifungal Agents; Crosses, Genetic; Drug Resistance, Microbial; Fluconazole; Ketoconazole; Meiosis; Mutagenesis; Neurospora crassa; Selection, Genetic; Triazoles | 1995 |
Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
Topics: Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Female; Fluconazole; Half-Life; Itraconazole; Mice; Microbial Sensitivity Tests; Triazoles | 1995 |
In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Triazoles | 1995 |
Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Mice; Mice, Inbred ICR; Triazoles | 1995 |
SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Fluconazole; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred Strains; Neutropenia; Triazoles | 1995 |
Efficacy of the triazole D0870 in a murine model of systemic histoplasmosis.
Topics: Animals; Antifungal Agents; Female; Fluconazole; Histoplasmosis; Liver; Mice; Spleen; Triazoles | 1995 |
Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata.
Topics: Antifungal Agents; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Triazoles | 1994 |
Disposition of azole antifungal agents. III. Binding of fluconazole and other azoles in rat liver.
Topics: Adrenal Glands; Animals; Antifungal Agents; Azoles; Blood Proteins; Fluconazole; Kidney; Liver; Rats; Rats, Sprague-Dawley; Tissue Distribution; Triazoles | 1994 |
Treatment of disseminated Torulopsis glabrata infection with DO870 and amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Synergism; Drug Therapy, Combination; Fluconazole; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Spleen; Triazoles | 1994 |
Utility of the triazole D0870 in the treatment of experimental systemic coccidioidomycosis.
Topics: Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluconazole; Liver; Lung; Mice; Mice, Inbred Strains; Spleen; Stereoisomerism; Triazoles | 1994 |
Pneumocystis carinii is resistant to imidazole antifungal agents.
Topics: Animals; Antifungal Agents; Ergosterol; Female; Fluconazole; Gas Chromatography-Mass Spectrometry; Itraconazole; Ketoconazole; Miconazole; Pneumocystis; Rats; Rats, Sprague-Dawley; Triazoles | 1994 |
Sch 39304, a new antifungal agent: oral and topical treatment of vaginal and superficial infections.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluconazole; Guinea Pigs; Miconazole; Tinea; Triazoles | 1993 |
Activities of the triazole D0870 in vitro and against murine blastomycosis.
Topics: Animals; Antifungal Agents; Blastomyces; Blastomycosis; Fluconazole; Male; Mice; Microbial Sensitivity Tests; Triazoles | 1993 |
Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alleles; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Electrophoresis; Enzymes; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles | 1995 |
In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomyces; Blastomycosis; Drug Evaluation, Preclinical; Fluconazole; Lethal Dose 50; Lung Diseases, Fungal; Male; Mice; Microbial Sensitivity Tests; Triazoles | 1996 |
Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays.
Topics: Antifungal Agents; Candida albicans; Cytochrome P-450 Enzyme System; Ergosterol; Fluconazole; Gas Chromatography-Mass Spectrometry; Humans; Microbial Sensitivity Tests; Microsomes; Structure-Activity Relationship; Triazoles | 1996 |
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Blood; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Rabbits; Triazoles | 1996 |
In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species.
Topics: Antifungal Agents; Candida; Candida albicans; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1996 |
In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Fluconazole; Fungi; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Thiazoles; Triazoles | 1996 |
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Brain Diseases; Candidiasis; Candidiasis, Oral; Cryptococcosis; Female; Fluconazole; Lung Diseases, Fungal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Thiazoles; Triazoles | 1996 |
Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis.
Topics: Animals; Antifungal Agents; Blood-Brain Barrier; Brain; Chromatography, High Pressure Liquid; Cross-Over Studies; Feasibility Studies; Fluconazole; Injections, Intravenous; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Spectrophotometry, Ultraviolet; Tissue Distribution; Triazoles | 1996 |
ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Fluconazole; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Triazoles | 1996 |
T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida; Candidiasis; Cryptococcus neoformans; Dogs; Fluconazole; Hydroxybutyrates; Itraconazole; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rabbits; Rats; Triazoles | 1997 |
Efficacies of two novel azole derivatives each containing a morpholine ring, UR-9746 and UR-9751, against systemic murine coccidioidomycosis.
Topics: Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Female; Fluconazole; Mice; Morpholines; Triazoles | 1997 |
In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Osmolar Concentration; Triazoles | 1996 |
Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Triazoles | 1997 |
In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests; Mouth; Pyrimidines; Triazoles; Voriconazole | 1997 |
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Triazoles | 1997 |
Evidence for and characterization of cytochrome P-450 in Neurospora crassa.
Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochromes b5; Cytosol; Enzyme Inhibitors; Fluconazole; Fungicides, Industrial; Microsomes; NADPH-Ferrihemoprotein Reductase; Neurospora crassa; Proadifen; Progesterone; Triazoles | 1997 |
Efficacy of D0870 treatment of experimental Candida vaginitis.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Triazoles; Vaginitis | 1997 |
In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida; Carbon Monoxide; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Ergosterol; Fluconazole; Itraconazole; Time Factors; Triazoles | 1997 |
Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Triazoles | 1997 |
The design and validation of a novel intravenous microdialysis probe: application to fluconazole pharmacokinetics in the freely-moving rat model.
Topics: Animals; Area Under Curve; Blood Proteins; Blood Specimen Collection; Equipment Design; Fluconazole; Male; Microdialysis; Protein Binding; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Triazoles; Vena Cava, Inferior | 1997 |
In vitro antifungal activity of novel azole derivatives with a morpholine ring, UR-9746 and UR-9751, and comparison with fluconazole.
Topics: Antifungal Agents; Culture Media; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Morpholines; Mycoses; Triazoles | 1997 |
A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
Topics: Antifungal Agents; Candida; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Sterols; Triazoles; Voriconazole | 1997 |
In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Culture Media; Fluconazole; Fungi; Griseofulvin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 1997 |
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
The effect of the new triazole, voriconazole (UK-109,496), on the interactions of Candida albicans and Candida krusei with endothelial cells.
Topics: Antifungal Agents; Candida albicans; Cell Adhesion; Cells, Cultured; Endothelium, Vascular; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Monocytes; Neutrophils; Pyrimidines; Recombinant Proteins; T-Lymphocytes, Regulatory; Triazoles; Voriconazole | 1998 |
In vitro activity of voriconazole against Candida species.
Topics: Antifungal Agents; Candida; Drug Evaluation, Preclinical; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Genotype; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth; North America; Pharynx; Phenotype; Pyrimidines; Triazoles; Voriconazole | 1998 |
Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Damage to yeast cells of Cryptococcus neoformans by voriconazole and fluconazole: a culture and microscopic study.
Topics: Antifungal Agents; Coloring Agents; Cryptococcus neoformans; Fluconazole; Humans; Pyrimidines; Time Factors; Triazoles; Voriconazole | 1998 |
In vitro activity of voriconazole against selected fungi.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Basidiomycota; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 1998 |
Anticryptococcal activity of voriconazole against Cryptococcus neoformans var. gatti vs var. neoformans: comparison with fluconazole and effect of human serum.
Topics: Antifungal Agents; Colony Count, Microbial; Cryptococcus neoformans; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.
Topics: Africa; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; United States; Voriconazole | 1999 |
Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Colorimetry; Drug Resistance, Microbial; Fluconazole; Humans; Microbial Sensitivity Tests; Tetrazolium Salts; Thiazoles; Triazoles | 1998 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Drug Resistance, Microbial; Fluconazole; Guinea Pigs; Male; Neutropenia; Pyrimidines; Random Allocation; Triazoles; Voriconazole | 1999 |
In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients.
Topics: Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 1999 |
Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; Hydrogen-Ion Concentration; Itraconazole; Male; Meningitis, Fungal; Microbial Sensitivity Tests; Osmolar Concentration; Phenotype; Pyrimidines; Staining and Labeling; Temperature; Triazoles; Voriconazole | 1999 |
Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 1999 |
Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Glucose; Microbial Sensitivity Tests; Pyrimidines; Spectrophotometry; Time Factors; Triazoles; Voriconazole | 1999 |
Effects of voriconazole on Candida glabrata in vitro.
Topics: Antifungal Agents; Candida; Fluconazole; Humans; Microbial Sensitivity Tests; Phospholipids; Pyrimidines; Sterols; Triazoles; Voriconazole | 1999 |
In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America.
Topics: Antifungal Agents; Candida; Dose-Response Relationship, Drug; Fluconazole; Humans; Itraconazole; Latin America; Microbial Sensitivity Tests; North America; Population Surveillance; Thiazoles; Triazoles | 1999 |
In-vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Quinazolines; Triazoles | 1999 |
Antifungal activities of D0870 against fluconazole-resistant Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Male; Mice; Mice, Inbred ICR; Triazoles | 1999 |
In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles | 1999 |
Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases.
Topics: Amphotericin B; Animals; Fluconazole; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liver; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Spleen; Time Factors; Triazoles; Trypanocidal Agents | 1999 |
Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species.
Topics: Antifungal Agents; Candida; Colorimetry; Coloring Agents; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Oxazines; Pyrimidines; Triazoles; Voriconazole; Xanthenes | 1999 |
Benzodihydrocarbazoles activity on triazole susceptible and resistant Candida sp.
Topics: Antifungal Agents; Candida; Carbazoles; Fluconazole; Microbial Sensitivity Tests; Mutagens; Salmonella typhimurium; Triazoles | 2000 |
Treatment of murine cryptococcal meningitis with UR-9751 and UR-9746.
Topics: Animals; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Meningitis, Cryptococcal; Mice; Microbial Sensitivity Tests; Morpholines; Survival Rate; Triazoles | 2000 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2000 |
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles | 2000 |
In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2000 |
In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2000 |
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole | 2000 |
Activity of voriconazole against Candida albicans and Candida krusei isolated since 1984.
Topics: Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2000 |
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2001 |
Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.
Topics: Antifungal Agents; Calibration; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
Application of capillary zone electrophoresis with off-line solid-phase extraction to in vitro metabolism studies of antifungals.
Topics: Acetic Acid; Acetonitriles; Antifungal Agents; Clotrimazole; Drug Stability; Electrophoresis, Capillary; Fluconazole; Humans; Itraconazole; Ketoconazole; Methanol; Microsomes, Liver; Molecular Structure; Molecular Weight; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Solvents; Triazoles; Verapamil; Voriconazole | 2001 |
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surv
Topics: Antifungal Agents; Candida; Candidiasis; Europe; Fluconazole; Fungemia; Humans; Latin America; North America; Pyrimidines; Sentinel Surveillance; Thiazoles; Triazoles; Voriconazole | 2001 |
In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles | 2001 |
[Synthesis and antifungal activity of 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted-2-propanols].
Topics: Antifungal Agents; Candida albicans; Fluconazole; Ketoconazole; Microbial Sensitivity Tests; Microsporum; Saccharomyces; Structure-Activity Relationship; Triazoles | 1997 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |
Synthesis and in vitro antifungal activities of novel triazole antifungal agent CS-758.
Topics: Antifungal Agents; Fluconazole; Fungi; Indicators and Reagents; Itraconazole; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Triazoles | 2001 |
Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2002 |
Genotyping and antifungal susceptibility of human subgingival Candida albicans isolates.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Dental Plaque; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Genetic Heterogeneity; HIV Infections; Humans; Itraconazole; Karyotyping; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Triazoles | 2002 |
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Female; Fluconazole; Histoplasmosis; Itraconazole; Liver; Mice; Spleen; Survival; Survival Analysis; Thiazoles; Triazoles | 2002 |
In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.
Topics: Antifungal Agents; Azoles; Candida; Dose-Response Relationship, Drug; Fluconazole; HIV Infections; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Mouth; Naphthalenes; Pyrimidines; Quality Control; Terbinafine; Triazoles; Voriconazole | 2002 |
Voriconazole and fluconazole susceptibility of Candida isolates.
Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Broth medium for microdilution susceptibility tests of fluconazole and voriconazole.
Topics: Antifungal Agents; Candida; Culture Media; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Triazoles; Voriconazole | 2002 |
Influence of voriconazole and fluconazole on Candida albicans in long-time continuous flow culture.
Topics: Aerobiosis; Antifungal Agents; Biofilms; Candida albicans; Fluconazole; Kinetics; Microbial Sensitivity Tests; Mycology; Pyrimidines; Triazoles; Voriconazole | 2002 |
Vulvovaginitis due to fluconazole resistant Candida albicans following self treatment with non-prescribed triazoles.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Nonprescription Drugs; Self Medication; Triazoles; Vulvovaginitis | 2002 |
Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.
Topics: Amphotericin B; Antifungal Agents; Area Under Curve; Candidiasis; Catheterization; Fluconazole; Half-Life; Microbial Sensitivity Tests; Microscopy, Electron; Pyrimidines; Triazoles; Voriconazole | 2002 |
In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole (SCH56592).
Topics: Antifungal Agents; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2002 |
Efficacy of CS-758, a novel triazole, against experimental fluconazole-resistant oropharyngeal candidiasis in mice.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Resistance, Fungal; Fluconazole; Male; Mice; Microbial Sensitivity Tests; Oropharynx; Tongue; Triazoles | 2003 |
Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Base Sequence; Blotting, Northern; Candida; Chromosome Mapping; Cloning, Molecular; Cytochrome P-450 Enzyme System; DNA, Complementary; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Fluconazole; Gene Deletion; Immunoblotting; Itraconazole; Lung; Molecular Sequence Data; Mutagenesis, Site-Directed; Oxidoreductases; Pneumocystis; Polymerase Chain Reaction; Protein Biosynthesis; Pyrimidines; Rats; Recombinant Proteins; RNA, Messenger; RNA, Ribosomal; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Triazoles; Voriconazole | 2003 |
Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood.
Topics: Antifungal Agents; Blood; Candida; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
Drug induced proteome changes in Candida albicans: comparison of the effect of beta(1,3) glucan synthase inhibitors and two triazoles, fluconazole and itraconazole.
Topics: Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Echinocandins; Electrophoresis, Gel, Two-Dimensional; Fluconazole; Fungal Proteins; Glucose; Glucosyltransferases; Image Processing, Computer-Assisted; Itraconazole; Kinetics; Mass Spectrometry; Membrane Proteins; Microscopy, Electron, Scanning; Microscopy, Phase-Contrast; Peptides, Cyclic; Proteome; Schizosaccharomyces pombe Proteins; Triazoles | 2003 |
Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei.
Topics: Amino Acid Sequence; Antifungal Agents; Candida; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Enzyme Inhibitors; Fluconazole; Models, Molecular; Molecular Sequence Data; Oxidoreductases; Protein Structure, Secondary; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2003 |
Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2003 |
Lack of cross-hepatotoxicity between fluconazole and voriconazole.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Liver; Liver Function Tests; Male; Pyrimidines; Transaminases; Triazoles; Voriconazole | 2003 |
Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole.
Topics: Antifungal Agents; Candida; Diffusion; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
Synthesis and antimycotic activity of N-azolyl-2,4-dihydroxythiobenzamides.
Topics: Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Thioamides; Triazoles | 2003 |
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.
Topics: Agar; Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2003 |
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole | 2003 |
[In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2003 |
In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Female; Fluconazole; Kidney; Mice; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2003 |
[In vitro activity of voriconazole and three other antifungal agents against dermatophytes].
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Pyrimidines; Species Specificity; Terbinafine; Triazoles; Trichophyton; Voriconazole | 2003 |
Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.
Topics: Antifungal Agents; Aspergillus fumigatus; Colorimetry; Fluconazole; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole | 2003 |
Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion.
Topics: Antifungal Agents; Candida; Candidiasis; Diffusion; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Cryptococcus neoformans; Fluconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Quinazolines; Rabbits; Survival Analysis; Triazoles | 2004 |
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2004 |
Stability of Mueller-Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazole.
Topics: Agar; Candida; Candida albicans; Culture Media; Fluconazole; Glucose; Methylene Blue; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2004 |
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.
Topics: Candida; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multicenter Studies as Topic; Probability; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2004 |
In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia.
Topics: Africa; Amphotericin B; Antifungal Agents; Cambodia; Cryptococcosis; Cryptococcus neoformans; Developing Countries; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pyrimidines; Risk Assessment; Sampling Studies; Triazoles; Voriconazole | 2004 |
Caspofungin: new indication. No progress in invasive candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; France; Humans; Peptides; Pyrimidines; Triazoles | 2004 |
In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2004 |
Alternatives to amphotericin B for Candida rugosa infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Fluconazole; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Organ Size; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole | 2004 |
Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Serotyping; Taiwan; Triazoles; Voriconazole | 2004 |
Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2004 |
In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles; Yeasts | 2004 |
Influence of voriconazole and fluconazole on reconstituted multilayered oesophageal epithelium infected by Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cell Line, Tumor; Epithelial Cells; Esophagitis; Esophagus; Fluconazole; Humans; Microbial Sensitivity Tests; Models, Biological; Pyrimidines; Triazoles; Voriconazole | 2004 |
In vitro activity of voriconazole against Candida species isolated in Taiwan.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole | 2004 |
Penetration of Candida biofilms by antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Colony Count, Microbial; Culture Media; Diffusion; Fluconazole; Flucytosine; Microscopy, Electron, Scanning; Mutation; Pyrimidines; Staphylococcus epidermidis; Triazoles; Voriconazole | 2004 |
Altered susceptibility of Candida glabrata bloodstream isolates to triazoles at clinically relevant pH values: comparison of the NCCLS M27-A2, Sensititre YeastOne, and Etest methods.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Hydrogen-Ion Concentration; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2004 |
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Fluconazole; Hematologic Neoplasms; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.
Topics: Antifungal Agents; Brain Abscess; Chronic Disease; Cryptococcus neoformans; Fluconazole; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Renal Insufficiency; Time Factors; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation.
Topics: Antifungal Agents; Double-Blind Method; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Research Design; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2004 |
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
Topics: Antifungal Agents; Candida glabrata; Candidiasis, Oral; Fluconazole; Head and Neck Neoplasms; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2004 |
Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Humans; Microbial Sensitivity Tests; Triazoles | 2005 |
Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods.
Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2005 |
[Synthesis and antifungal activity of novel triazole antifungal agents].
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Molecular Structure; Naphthalenes; Structure-Activity Relationship; Terbinafine; Triazoles | 2004 |
In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Saccharomyces cerevisiae; Species Specificity; Triazoles; Voriconazole | 2005 |
In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine; Thiazoles; Triazoles; Yeasts | 2005 |
Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages.
Topics: Antifungal Agents; Candida; Candida glabrata; Colony Count, Microbial; Drug Resistance, Fungal; Fluconazole; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon-gamma; Macrophages; Monocytes; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2005 |
In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Fluconazole; Injections, Intravenous; Male; Mice; Mice, Inbred CBA; Mice, Inbred DBA; Microbial Sensitivity Tests; Species Specificity; Triazoles | 2005 |
In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
Topics: Antifungal Agents; Candida glabrata; Candidiasis, Oral; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Triazoles | 2005 |
In vitro antifungal activity of ZJ-522, a new triazole restructured from fluconazole and butenafine, against clinically important fungi in comparison with fluconazole and butenafine.
Topics: Antifungal Agents; Benzylamines; Fluconazole; Fungi; Microbial Sensitivity Tests; Naphthalenes; Triazoles | 2005 |
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
Topics: Antifungal Agents; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2005 |
In vitro investigation of antifungal activities of phenotypic variation Candida albicans strains against fluconazole, itraconazole and voriconazole.
Topics: Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Phenotype; Pyrimidines; Triazoles; Voriconazole | 2005 |
[In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis].
Topics: Antifungal Agents; Arthrodermataceae; Ascomycota; Dermatomycoses; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2005 |
Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Drug Synergism; Flow Cytometry; Fluconazole; Fungal Proteins; Ibuprofen; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Staining and Labeling; Triazoles; Voriconazole | 2005 |
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Reproducibility of Results; Spectrophotometry; Triazoles; Voriconazole | 2005 |
Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth Diseases; Mycoses; Neoplasms; Palliative Care; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2005 |
DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Soil Microbiology; Spain; Triazoles; Voriconazole | 2005 |
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Israel; Itraconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2005 |
Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole.
Topics: Adolescent; Adult; Candida glabrata; Female; Fluconazole; Fungemia; Humans; Leukemia; Male; Microbial Sensitivity Tests; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2005 |
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2005 |
Posaconazole therapy for systemic coccidioidomycosis in a chimpanzee (Pan troglodytes): a case report.
Topics: Animals; Antibodies, Fungal; Antifungal Agents; Ape Diseases; Blood; Central Nervous System Fungal Infections; Cerebrospinal Fluid; Coccidioides; Coccidioidomycosis; Fluconazole; Laparoscopy; Male; Pan troglodytes; Triazoles | 2005 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole | 2005 |
Cryptococcus gattii: in vitro susceptibility to the new antifungal albaconazole versus fluconazole and voriconazole.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Soil Microbiology; Triazoles; Voriconazole | 2005 |
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2005 |
Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy.
Topics: Antifungal Agents; Blood; Candida; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fatal Outcome; Female; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Middle Aged; Triazoles | 2006 |
Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
Topics: Candida albicans; Candidiasis; Drug Resistance; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
Synthesis and antimicrobial activity of some new 1-alkyl-2-alkylthio-1,2,4-triazolobenzimidazole derivatives.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Bacteria; Benzimidazoles; Chemical Phenomena; Chemistry, Physical; Fluconazole; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Penicillins; Triazoles | 2006 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Biomass; Caspofungin; Cryptococcus neoformans; Dose-Response Relationship, Drug; Echinocandins; Enzyme-Linked Immunosorbent Assay; Fluconazole; Formazans; Lipopeptides; Melanins; Microbial Sensitivity Tests; Microscopy, Confocal; Peptides, Cyclic; Plankton; Pyrimidines; Triazoles; Voriconazole | 2006 |
Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amino Acid Substitution; Antifungal Agents; Binding Sites; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Histoplasma; Histoplasmosis; Humans; Microbial Sensitivity Tests; Mutation; Triazoles | 2006 |
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2006 |
In vitro activities of new and conventional antimycotics against fluconazole-susceptible and non-susceptible Brazilian Candida spp. isolates.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Quinazolines; Thiazoles; Triazoles | 2006 |
Control of a Candida glabrata prosthetic endovascular infection with posaconazole.
Topics: Candida glabrata; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Triazoles | 2006 |
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial.
Topics: Antifungal Agents; Arthrodermataceae; Clinical Trials as Topic; Fluconazole; Griseofulvin; Humans; Microbial Sensitivity Tests; Pyrimidines; Tinea Capitis; Triazoles; Voriconazole | 2006 |
Aspergillus meningitis following spinal anaesthesia for caesarean section in Colombo, Sri Lanka.
Topics: Abducens Nerve Diseases; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antifungal Agents; Aspergillosis; Brain; Cesarean Section; Diabetes, Gestational; Fatal Outcome; Female; Fluconazole; Glasgow Coma Scale; Humans; Meningitis, Fungal; Pregnancy; Pyrimidines; Respiration, Artificial; Sri Lanka; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Use of the BIOMIC Video System to evaluate the susceptibility of clinical yeast isolates to fluconazole and voriconazole by a disk diffusion method.
Topics: Candida; Candidiasis; Fluconazole; Humans; Image Processing, Computer-Assisted; Microbial Sensitivity Tests; Microscopy, Video; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Candida albicans induced spondylodiscitis of the cervical spine of a polytraumatized patient].
Topics: Adult; Antifungal Agents; Candidiasis; Cervical Vertebrae; Combined Modality Therapy; Discitis; Epidural Abscess; Fluconazole; Follow-Up Studies; Head Movements; Humans; Lung Diseases, Fungal; Male; Multiple Trauma; Pyrimidines; Radiography; Triazoles; Voriconazole | 2006 |
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Azoles; Chlorhexidine; Communicable Diseases, Emerging; Drug Synergism; Fluconazole; Guanidines; Humans; Microbial Sensitivity Tests; Mycoses; Polymers; Pyrimidines; Triazoles; Trichoderma; Voriconazole | 2006 |
Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Male; Middle Aged; Panophthalmitis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
Topics: Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Global Health; Humans; Lipopeptides; Peptides, Cyclic; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2006 |
Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2006 |
Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Injections; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Visual Acuity; Vitreous Body; Voriconazole | 2006 |
Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Humans; Laboratories; Microbial Sensitivity Tests; Predictive Value of Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 2007 |
Effect of antifungal treatment in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Geotrichosis; Geotrichum; Immunocompromised Host; Immunosuppressive Agents; Kidney; Liver; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Change of the blood concentration of tacrolimus after the switch from fluconazole to voriconazole in patients receiving allogeneic hematopoietic stem cell transplantation.
Topics: Fluconazole; Humans; Immunosuppressive Agents; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Tacrolimus; Triazoles; Voriconazole | 2006 |
Echinocandins for candidemia.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Humans; Pyrimidines; Triazoles; Voriconazole | 2006 |
Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, cas
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
Antifungal activities of azole agents against the Malassezia species.
Topics: Antifungal Agents; Azoles; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Tinea Versicolor; Triazoles; Voriconazole | 2007 |
Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is common.
Topics: Aniline Compounds; Aryl Hydrocarbon Hydroxylases; Benzodioxoles; Binding Sites; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fluconazole; Heme; Humans; Imidazoles; Itraconazole; Kinetics; Ligands; Light; Models, Chemical; Molecular Structure; NADP; Nonlinear Dynamics; Protein Binding; Pyrimidines; Recombinant Proteins; Reference Standards; Regression Analysis; Spectrum Analysis; Sulfaphenazole; Triazoles | 2007 |
Prophylaxis and aspergillosis--has the principle been proven?
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Graft vs Host Disease; Humans; Itraconazole; Mycoses; Neutropenia; Opportunistic Infections; Triazoles | 2007 |
Voriconazole and multidrug resistance in Candida albicans.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Candida albicans; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Genes, MDR; Membrane Transport Proteins; Microbial Sensitivity Tests; Pyrimidines; Rhodamines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2007 |
A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mutation; Oxidative Phosphorylation; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Antifungal susceptibility testing of Trichophyton rubrum by E-test.
Topics: Antifungal Agents; Cells, Cultured; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Tinea; Triazoles; Trichophyton; Voriconazole | 2007 |
Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
Posaconazole.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Capsules; Drug Approval; Drug Design; Economics, Pharmaceutical; Fluconazole; Humans; Injections, Intravenous; Itraconazole; Molecular Structure; Randomized Controlled Trials as Topic; Suspensions; Technology, Pharmaceutical; Treatment Failure; Triazoles; United States | 2007 |
Comparison of tablet and disk diffusion methods for fluconazole and voriconazole in vitro activity testing against clinical yeast isolates.
Topics: Antifungal Agents; Candida; Cells, Cultured; Drug Resistance, Fungal; Fluconazole; Humans; In Vitro Techniques; Linear Models; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Saccharomyces; Triazoles; Voriconazole | 2007 |
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2007 |
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Topics: Antifungal Agents; Candida; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Population Surveillance; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Colony Count, Microbial; Disease Models, Animal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles; Vagina | 2007 |
Acquired resistance to echinocandins in Candida albicans: case report and review.
Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genotype; HIV Infections; HIV-1; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2007 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
Posaconazole susceptibility testing against Candida species: comparison of broth microdilution and E-test methods.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Dimethyl Sulfoxide; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Polyethylene Glycols; Solvents; Triazoles | 2007 |
Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Chemistry, Pharmaceutical; Drug Design; Drug Resistance, Fungal; Fluconazole; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Models, Chemical; Time Factors; Triazoles | 2007 |
Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcus neoformans; Drug Resistance, Viral; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Time Factors; Triazoles; Voriconazole | 2007 |
Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).
Topics: Antifungal Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line; Cell Survival; Chlorophyll; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Flow Cytometry; Fluconazole; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Itraconazole; Ketoconazole; Neoplasm Proteins; Pyrimidines; Topotecan; Transfection; Triazoles; Voriconazole | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Opportunistic Infections; Triazoles | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Research Design; Triazoles | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Bilirubin; Chemical and Drug Induced Liver Injury; Fluconazole; Graft vs Host Disease; Humans; Liver Diseases; Mycoses; Transaminases; Triazoles | 2007 |
In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
Topics: Antifungal Agents; Arthrodermataceae; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Triazoles; Voriconazole | 2007 |
New guinea pig model of Cryptococcal meningitis.
Topics: Animals; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Fluconazole; Guinea Pigs; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2007 |
In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Fluconazole; France; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2007 |
In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolates.
Topics: Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Antifungal susceptibility of Candida species using the Clinical and Laboratory Standards Institute disk diffusion and broth microdilution methods.
Topics: Antifungal Agents; Candida; Disk Diffusion Antimicrobial Tests; Fluconazole; Humans; Microbial Sensitivity Tests; Microbiological Techniques; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation; Drug Resistance, Fungal; Fluconazole; Humans; Injections, Intravenous; Molecular Structure; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.
Topics: Antifungal Agents; Candida albicans; Culture Media; Drug Resistance, Fungal; Fluconazole; Histidine Kinase; Microbial Sensitivity Tests; Mutation; Phenotype; Phosphorylation; Protein Kinases; Pyrimidines; Signal Transduction; Triazoles; Voriconazole | 2007 |
Voriconazole inhibits melanization in Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Cell Line; Cryptococcus neoformans; Fluconazole; Gene Expression Regulation, Fungal; Laccase; Macrophages; Melanins; Mice; Microbial Sensitivity Tests; Phagocytosis; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea.
Topics: Antifungal Agents; Azoles; Bacteremia; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2007 |
Subgingival distribution of yeast and their antifungal susceptibility in immunocompetent subjects with and without dental devices.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Dental Plaque; Drug Resistance, Fungal; Female; Fluconazole; Gingivitis; Humans; Immunocompetence; Male; Microbial Sensitivity Tests; Middle Aged; Orthodontic Appliances; Periodontitis; Pyrimidines; Triazoles; Voriconazole | 2007 |
Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2008 |
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Pyrimidines; Rhodotorula; Triazoles; Trichosporon; Voriconazole | 2008 |
Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.
Topics: Antifungal Agents; Biomarkers; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Regression Analysis; Triazoles; Voriconazole | 2008 |
[Identification and susceptibility against fluconazole and albaconazole of 100 yeasts' strains isolated from vaginal discharge].
Topics: Adult; Antifungal Agents; Body Fluids; Candida; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Middle Aged; Quinazolines; Triazoles; Trichosporon; Vagina | 2007 |
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
Topics: Africa; Antifungal Agents; Asia; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Europe; Fluconazole; Fungemia; Global Health; Humans; Latin America; Microbial Sensitivity Tests; Middle East; North America; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2008 |
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
Topics: Antifungal Agents; Aspergillus; Candida; Fluconazole; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2008 |
MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii.
Topics: Animals; Antifungal Agents; Bird Diseases; Columbidae; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Triazoles; Voriconazole | 2008 |
Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.
Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Kidney; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles | 2008 |
Synthesis and antimicrobial activity of certain new 1,2,4-triazolo[1,5-a]pyrimidine derivatives.
Topics: Acetates; Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Fluconazole; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrocarbons, Brominated; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Mitosporic Fungi; Molecular Structure; Pyrimidines; Spectrophotometry, Infrared; Structure-Activity Relationship; Triazoles | 2008 |
[Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Interactions; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2008 |
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole; Yeasts | 2008 |
Imidazole antifungals, but not triazole antifungals, increase membrane Zn2+ permeability in rat thymocytes Possible contribution to their cytotoxicity.
Topics: Animals; Antifungal Agents; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Chlorides; Clotrimazole; Dose-Response Relationship, Drug; Fluconazole; Imidazoles; Itraconazole; Male; Rats; Rats, Wistar; Structure-Activity Relationship; T-Lymphocytes; Thymus Gland; Triazoles; Zinc Compounds | 2008 |
In vitro susceptibility of Cryptococcus gattii clinical isolates.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Triazoles | 2008 |
Treatment of aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neutropenia; Triazoles | 2008 |
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult | 2008 |
Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Pyrimidines; Triazoles; Venezuela; Voriconazole; Young Adult | 2009 |
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2008 |
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands.
Topics: Adult; Aged; Antifungal Agents; Costs and Cost Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Netherlands; Neutropenia; Randomized Controlled Trials as Topic; Triazoles | 2008 |
Design, synthesis, and antifungal activity of triazole and benzotriazole derivatives.
Topics: Antifungal Agents; Catalytic Domain; Clotrimazole; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungi; Models, Molecular; Software; Sterol 14-Demethylase; Triazoles | 2009 |
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2008 |
Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Everolimus; Fatal Outcome; Fluconazole; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Pyrimidines; Sirolimus; Triazoles; Voriconazole | 2008 |
National surveillance of antifungal susceptibility of Candida species in South Korean hospitals.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Republic of Korea; Triazoles; Voriconazole | 2009 |
Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
Topics: Antifungal Agents; Culture Media; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Cells, Cultured; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Leukotriene B4; Molecular Structure; Neutrophils; Platelet Activating Factor; Pyrimidines; Triazoles; Voriconazole | 2008 |
Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
Topics: Adolescent; Adult; Aged; Argentina; Candida; Candidiasis, Oral; Dental Plaque; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Periodontal Pocket; Phenotype; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2008 |
Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Serotyping; Triazoles; Voriconazole | 2009 |
Carbon analogs of antifungal dioxane-triazole derivatives: synthesis and in vitro activities.
Topics: Antifungal Agents; Carbon; Chemistry, Pharmaceutical; Dioxanes; Drug Design; Epoxy Compounds; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Models, Chemical; Stereoisomerism; Triazoles | 2008 |
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Topics: Africa; Antifungal Agents; Asia, Southeastern; Drug Resistance, Fungal; Europe; Fluconazole; Humans; Latin America; Microbial Sensitivity Tests; Middle East; Mycoses; North America; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2009 |
Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
Topics: Animals; Antifungal Agents; Brain; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Fluconazole; Kidney; Male; Mice; Neutropenia; Nitriles; Pyridines; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations.
Topics: Antifungal Agents; Azoles; Biological Assay; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2009 |
Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia.
Topics: Antifungal Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Monte Carlo Method; Multicenter Studies as Topic; Mycoses; Neutropenia; Triazoles | 2008 |
Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
Topics: Agar; Amphotericin B; Antifungal Agents; Cryptococcus; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2008 |
Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin.
Topics: Administration, Topical; Adult; Aged; Alternaria; Antifungal Agents; Caspofungin; Cataract Extraction; Contact Lenses; Corneal Stroma; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Eye Injuries; Female; Fluconazole; Humans; Injections; Keratitis; Lipopeptides; Male; Medical Records; Middle Aged; Pyrimidines; Steroids; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues.
Topics: Animals; Antifungal Agents; Bile Acids and Salts; Candida albicans; Candidiasis; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Fluconazole; Humans; Inhibitory Concentration 50; Mice; Models, Chemical; Triazoles | 2009 |
Susceptibility to voriconazole, fluconazole, and ketoconazole of yeast isolated from patients with hematological malignancies.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hematologic Neoplasms; Humans; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; HIV Seropositivity; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2009 |
[Saccharomyces cerevisiae fungemia associated with multifocal pneumonia in a patient with alcohol-related hepatic cirrhosis].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Liver Cirrhosis, Alcoholic; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Saccharomyces cerevisiae; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Lack of allergic cross-reactivity between fluconazole and voriconazole.
Topics: Aged; Antifungal Agents; Cross Reactions; Drug Hypersensitivity; Fluconazole; Humans; Liver; Male; Pyrimidines; Triazoles; Voriconazole | 2009 |
In vitro activities of fluconazole and voriconazole against clinical isolates of Candida spp. determined by disk diffusion testing in Turin, Italy.
Topics: Antifungal Agents; Candida; Diffusion; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole.
Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Wood | 2009 |
Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols.
Topics: Antifungal Agents; Catalytic Domain; Chemistry, Pharmaceutical; Computer Simulation; Crystallography, X-Ray; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Models, Chemical; Propanols; Protein Binding; Triazoles | 2009 |
Candida parapsilosis endocarditis in aged patient.
Topics: Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Endocarditis; Female; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole | 2009 |
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2009 |
Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents, Phytogenic; Drug Interactions; Female; Fluconazole; Humans; Male; Middle Aged; Peristalsis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Retrospective Studies; Triazoles; Vincristine; Voriconazole | 2009 |
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2009 |
Dynamics of in vitro acquisition of resistance by Candida parapsilosis to different azoles.
Topics: Antifungal Agents; Biosynthetic Pathways; Candida; Drug Resistance, Fungal; Ergosterol; Fluconazole; Humans; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2009 |
In vitro activity of voriconazole against Mexican oral yeast isolates.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; HIV Infections; Humans; Mexico; Microbial Sensitivity Tests; Mouth; Pharynx; Pyrimidines; Triazoles; Voriconazole | 2010 |
Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.
Topics: Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2009 |
In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Candidiasis; Colony Count, Microbial; Ear Diseases; Fluconazole; Humans; Itraconazole; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Synthesis of novel 3-(1-(1-substituted piperidin-4-yl)-1H-1,2,3-triazol-4-yl)-1,2,4-oxadiazol-5(4H)-one as antifungal agents.
Topics: Antifungal Agents; Fluconazole; Miconazole; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Triazoles | 2009 |
Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.
Topics: Anisomycin; Antifungal Agents; Biological Transport; Candida albicans; Curcumin; Cycloheximide; Drug Synergism; Enzyme Inhibitors; Fluconazole; Itraconazole; Ketoconazole; Methotrexate; Miconazole; Multidrug Resistance-Associated Proteins; Pyrimidines; Rhodamines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2009 |
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2009 |
Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
Topics: Administration, Intravaginal; Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Female; Fluconazole; Mice; Mice, Inbred BALB C; Pyrimidines; Treatment Outcome; Triazoles; Vagina; Voriconazole | 2009 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Italy; Microbial Sensitivity Tests; Outpatient Clinics, Hospital; Prevalence; Pyrimidines; Recurrence; Triazoles; Vagina; Voriconazole | 2009 |
Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole | 2009 |
Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection.
Topics: Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Fluconazole; Humans; Itraconazole; Ketoconazole; Pyrimidines; Quality Control; Reproducibility of Results; Spectrophotometry, Ultraviolet; Time Factors; Triazoles; Ultraviolet Rays; Voriconazole | 2009 |
[Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods].
Topics: Antifungal Agents; Dipodascus; Fluconazole; Geotrichosis; Humans; Itraconazole; Microbial Sensitivity Tests; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Efficacy of albaconazole against Candida albicans in a vaginitis model.
Topics: Administration, Oral; Animals; Antifungal Agents; Candida albicans; Female; Fluconazole; Mice; Mice, Inbred BALB C; Quinazolines; Triazoles; Vaginitis | 2009 |
Can density functional theory (DFT) be used as an aid to a deeper understanding of tandem mass spectrometric fragmentation pathways?
Topics: Antifungal Agents; Fluconazole; Molecular Structure; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2009 |
Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.
Topics: Antifungal Agents; Candida; Diagnostic Errors; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Quality Assurance, Health Care; Sensitivity and Specificity; Triazoles; Voriconazole | 2009 |
[Cryptococcal meningitis with a fatal outcome in an immunocompetent adult].
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Fatal Outcome; Fluconazole; Headache; Hearing Loss, Bilateral; Humans; Immunocompetence; Intracranial Hypertension; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Spinal Puncture; Triazoles; Voriconazole | 2010 |
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.
Topics: Adult; Antifungal Agents; Chemoprevention; Female; Fluconazole; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2010 |
Effects of antifungal agents in sap activity of Candida albicans isolates.
Topics: Antifungal Agents; Aspartic Acid Proteases; Candida albicans; Candidiasis; Culture Media; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests; Mouth Mucosa; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole | 2010 |
Discovery of highly potent novel antifungal azoles by structure-based rational design.
Topics: Antifungal Agents; Azoles; Binding Sites; Computer Simulation; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Hydrogen Bonding; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole | 2009 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts | 2010 |
Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT.
Topics: Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Multivariate Analysis; Mycoses; Sensitivity and Specificity; Treatment Outcome; Triazoles | 2010 |
Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Caspofungin; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2010 |
Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Blood; Candida tropicalis; Candidiasis; Catheterization; Cell Adhesion; Cells, Cultured; Enzymes; Epithelial Cells; Equipment and Supplies; Fluconazole; Fungal Proteins; Hemolysin Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Urine; Virulence Factors; Voriconazole | 2010 |
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Topics: Analysis of Variance; Antifungal Agents; Arthrodermataceae; Candida; Colombia; Dose-Response Relationship, Drug; Fluconazole; Fungi; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2010 |
Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods.
Topics: Amphotericin B; Antifungal Agents; Automation; Candida; Candidiasis; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pyrimidines; Statistics as Topic; Triazoles; Voriconazole | 2010 |
In vitro activities of azole antifungal agents against Propionibacterium acnes isolated from patients with acne vulgaris.
Topics: Acne Vulgaris; Antifungal Agents; Azoles; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Phytotherapy; Propionibacterium acnes; Pyrimidines; Triazoles; Voriconazole | 2010 |
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Antifungal susceptibility testing of Candida isolates from the Candida surveillance study.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.
Topics: Antifungal Agents; Candida glabrata; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Endpoint Determination; Fluconazole; Itraconazole; Lipopeptides; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2010 |
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
Topics: Africa; Americas; Antifungal Agents; Asia; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Europe; Fluconazole; Geography; Humans; Microbial Sensitivity Tests; Middle East; Pyrimidines; Triazoles; Voriconazole | 2010 |
Renal allograft loss due to overwhelming invasive Candida infection.
Topics: Adult; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
EUCAST breakpoints for antifungals.
Topics: Antifungal Agents; Candida; Computer Simulation; Drug Resistance, Fungal; Europe; Fluconazole; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Pyrimidines; Triazoles; Voriconazole | 2010 |
New onset of bilateral multifocal coccidioidomycosal choroiditis in a patient on oral fluconazole.
Topics: Administration, Oral; Antifungal Agents; Choroiditis; Coccidioides; Coccidioidomycosis; Eye Infections, Fungal; Fluconazole; Functional Laterality; Fungemia; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Visual Acuity; Voriconazole | 2010 |
Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole.
Topics: Amino Acid Sequence; Antifungal Agents; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Fluconazole; Models, Molecular; Molecular Sequence Data; Protein Binding; Protein Structure, Tertiary; Sequence Alignment; Triazoles; Trypanosoma brucei brucei; Trypanosoma cruzi | 2010 |
QSAR model for predicting the fungicidal action of 1,2,4-triazole derivatives against Candida albicans.
Topics: Antifungal Agents; Artificial Intelligence; Candida albicans; Chemical Phenomena; Drug Design; Fluconazole; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Molecular Dynamics Simulation; Quantitative Structure-Activity Relationship; Regression Analysis; Software; Triazoles | 2010 |
[Susceptibility to fluconazole and voriconazole of Candida species isolated from intensive care units patients in Medellin, Colombia (2001-2007)].
Topics: Antifungal Agents; Candida; Colombia; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Characterization of yeasts colonizing in healthy individuals.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Carrier State; Female; Fluconazole; Human Experimentation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Pyrimidines; Taiwan; Triazoles; Voriconazole; Yeasts; Young Adult | 2011 |
Comparison of Vitek identification and antifungal susceptibility testing methods to DNA sequencing and Sensititre YeastOne antifungal testing.
Topics: Amphotericin B; Candida; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Triazoles; Voriconazole | 2011 |
Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.
Topics: Antifungal Agents; Area Under Curve; Cytochrome P-450 CYP3A; Drug Interactions; Fluconazole; Humans; Itraconazole; Microsomes, Liver; Pyrimidines; Triazoles; Voriconazole | 2010 |
In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens.
Topics: Antifungal Agents; Dipodascus; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Rhodotorula; Saccharomyces cerevisiae; Triazoles; Trichosporon; Voriconazole | 2010 |
Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).
Topics: Antifungal Agents; Azoles; Candida albicans; Econazole; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Protein Binding; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2010 |
Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Geotrichum; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B.
Topics: Amino Acid Sequence; Aspergillus fumigatus; Azoles; Clotrimazole; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Isoenzymes; Itraconazole; Lanosterol; Molecular Sequence Data; Protein Binding; Pyrimidines; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Substrate Specificity; Triazoles; Voriconazole | 2010 |
Are disk diffusion and Etest methods reliable for detecting Candida glabrata and other species' susceptibility to fluconazole and voriconazole?
Topics: Antifungal Agents; Candida glabrata; Disk Diffusion Antimicrobial Tests; False Positive Reactions; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2010 |
Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2010 |
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14α-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B.
Topics: Anti-Bacterial Agents; Aspergillus fumigatus; Azoles; Clotrimazole; Cytochrome P-450 Enzyme System; Doxycycline; Ergosterol; Fluconazole; Fungal Proteins; Genetic Complementation Test; Itraconazole; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole | 2010 |
Cystoid macular edema secondary to fluconazole toxicity.
Topics: Administration, Oral; Aged; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluconazole; Fluorescein Angiography; Fundus Oculi; Humans; Macular Edema; Pyrimidines; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triazoles; Voriconazole | 2010 |
[Species distribution and antifungal susceptibilities of yeast clinical isolates from three hospitals in Korea, 2001 to 2007].
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Hospitals; Humans; Pyrimidines; Republic of Korea; Rhodotorula; Triazoles; Trichosporon; Voriconazole; Yeasts | 2010 |
Bloodstream yeast infections in a university hospital in Northeast Turkey: a 4-year survey.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole | 2011 |
In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Animals; Antifungal Agents; Cryptococcus gattii; Environmental Microbiology; Fluconazole; Flucytosine; Genotype; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
The effect of antifungal treatment on the vaginal flora of women with vulvo-vaginal yeast infection with or without bacterial vaginosis.
Topics: Administration, Oral; Antifungal Agents; Bacteria; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Triazoles; Vaginosis, Bacterial | 2011 |
In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. by E-test method.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2010 |
Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.
Topics: Antifungal Agents; Antineoplastic Agents; Canada; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Economic; Mycoses; Myelodysplastic Syndromes; Neoplasms; Randomized Controlled Trials as Topic; Triazoles | 2011 |
Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Lung; Mice; Mice, Inbred BALB C; Mice, SCID; Pyrimidines; Rodent Diseases; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole; Yeasts | 2011 |
Synthesis, molecular docking, and biological evaluation of novel triazole derivatives as antifungal agents.
Topics: Antifungal Agents; Computer Simulation; Drug Design; Fluconazole; Fungi; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Triazoles | 2010 |
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Drug Administration Routes; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Tunisia; Voriconazole | 2011 |
In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole | 2011 |
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of ep
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Clinical experience of anidulafungin for the treatment of patients with documented candidemia.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidemia; Catheters, Indwelling; Cross Infection; Echinocandins; Female; Fluconazole; Humans; Italy; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Design, synthesis and antifungal evaluation of 1-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-1H-1,2,4-triazol-5(4H)-one.
Topics: Antifungal Agents; Candida albicans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2011 |
Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.
Topics: Antifungal Agents; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility testing and candidaemia at a tertiary referral hospital.
Topics: Antifungal Agents; Candidemia; Cross Infection; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Transcriptional profiling of azole-resistant Candida parapsilosis strains.
Topics: Antifungal Agents; Azoles; Candida; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Profiling; Microbial Sensitivity Tests; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2011 |
Oral Candida isolates among HIV-infected subjects in Nigeria.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole | 2011 |
Design, synthesis and molecular docking studies of novel triazole as antifungal agent.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Propanols; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole | 2011 |
Diagnosis and treatment of fungal infection after liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Liver Transplantation; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
Topics: Antifungal Agents; Candida; Candidemia; Cross Infection; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Intensive Care Units; Italy; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2011 |
In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.
Topics: Antitubercular Agents; Drug Combinations; Drug Interactions; Ethambutol; Fluconazole; Histoplasma; Isoniazid; Itraconazole; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2011 |
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method.
Topics: Antifungal Agents; Candida; Caspofungin; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
Design, synthesis, and biological evaluation of 1-[(biarylmethyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as potent antifungal agents: new insights into structure-activity relationships.
Topics: Antifungal Agents; Aspergillus fumigatus; Binding Sites; Candida albicans; Catalytic Domain; Computer Simulation; Drug Design; Fluconazole; Hydrogen Bonding; Microbial Sensitivity Tests; Propanols; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2011 |
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Necrosis; Pentamidine; Phosphorylcholine; Pyrimidines; Skin Diseases, Parasitic; Skin Ulcer; Sulfadoxine; Triazoles; Voriconazole | 2011 |
Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases.
Topics: Adult; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fluconazole; Humans; Lipopeptides; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Trichosporonosis; Voriconazole; Young Adult | 2011 |
Comparative in vitro activities of fluconazole, voriconazole, and MXP-4509 against Romanian blood yeast isolates.
Topics: Antifungal Agents; Blood; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Romania; Triazoles; Voriconazole; Yeasts | 2011 |
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts | 2011 |
Successful management of an intracranial phaeohyphomycotic fungal granuloma in a dog.
Topics: Animals; Antifungal Agents; Cerebral Phaeohyphomycosis; Dog Diseases; Dogs; Fluconazole; Granuloma; Male; Pyrimidines; Triazoles; Voriconazole | 2011 |
A 1:1 cocrystal of fluconazole with salicylic acid.
Topics: Benzoates; Crystallography, X-Ray; Dimerization; Fluconazole; Hydrogen Bonding; Molecular Structure; Salicylic Acid; Triazoles | 2011 |
Evaluation of saliva flow rates, Candida colonization and susceptibility of Candida strains after head and neck radiation.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Colony Count, Microbial; Dental Caries; Drug Resistance, Fungal; Female; Fluconazole; Head and Neck Neoplasms; Humans; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Pyrimidines; Radiation Injuries; Saliva; Salivary Glands; Secretory Rate; Triazoles; Voriconazole; Xerostomia | 2012 |
Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method.
Topics: Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole | 2011 |
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cross Infection; Echinocandins; Female; Fluconazole; Hospitals; Humans; Italy; Itraconazole; Lipopeptides; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Miconazole; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; Fever; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Nausea; Pyrimidines; Recurrence; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2011 |
Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles.
Topics: Adolescent; Adult; Antifungal Agents; Coccidioides; Coccidioidomycosis; Cohort Studies; Exostoses; Female; Fluconazole; Fluorides; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Periostitis; Pyrimidines; Triazoles; United States; Voriconazole | 2012 |
SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A).
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genetic Complementation Test; Genotype; Humans; Microbial Sensitivity Tests; Organisms, Genetically Modified; Pyrimidines; Real-Time Polymerase Chain Reaction; Sterol Regulatory Element Binding Proteins; Transcription, Genetic; Triazoles; Voriconazole | 2012 |
[Synthesis and antimicrobial evaluation of coumarin-based benzotriazoles and their synergistic effects with chloromycin and fluconazole].
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Chloramphenicol; Coumarins; Drug Synergism; Fluconazole; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Methicillin-Resistant Staphylococcus aureus; Staphylococcus aureus; Triazoles | 2011 |
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Genotype; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation, Missense; Phenylalanine; Pyrimidines; Sterol 14-Demethylase; Survival Rate; Triazoles; Tyrosine; Voriconazole | 2012 |
A case of fluconazole, voriconazole-resistant Cryptococcus neoformans isolated from and immunocompetent patient.
Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Immunocompetence; Male; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2011 |
Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Meningoencephalitis; Microbial Sensitivity Tests; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2012 |
Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Taiwan; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2012 |
A murine model of Cryptococcus gattii meningoencephalitis.
Topics: Animals; Antifungal Agents; Antigens, Fungal; Brain; Colony Count, Microbial; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disease Models, Animal; Fluconazole; Histocytochemistry; Meningoencephalitis; Mice; Mice, Inbred ICR; Survival Analysis; Triazoles | 2012 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole | 2012 |
Recurrent fungal iris granuloma in a 10-year-old child.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Granuloma; Humans; Iris Diseases; Pyrimidines; Recurrence; Treatment Outcome; Triazoles; Voriconazole | 2012 |
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2013 |
The first Korean case of candidemia due to Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheterization, Central Venous; Female; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Coccidioidal endophthalmitis in immunocompetent person, California, USA.
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Eye Infections, Fungal; Fluconazole; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Ultrasonography; Voriconazole | 2012 |
Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Azoles; Base Sequence; Biological Transport; Candida glabrata; Drug Resistance, Multiple, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation, Missense; Pyrimidines; Saccharomyces cerevisiae; Sequence Analysis, DNA; Sterol 14-Demethylase; Sterols; Triazoles; Voriconazole | 2012 |
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence.
Topics: Adult; Amino Acid Substitution; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cell Membrane; Chemoprevention; Drug Resistance, Fungal; Female; Fluconazole; Gas Chromatography-Mass Spectrometry; Gene Expression Profiling; Humans; Mice; Microbial Sensitivity Tests; Middle Aged; Mutant Proteins; Oxidoreductases; Pyrimidines; Sterols; Triazoles; Virulence; Voriconazole | 2012 |
[Susceptibility to azoles and amphotericin B of isolates of Candida spp. Experience of a university health network, between 2004 and 2010].
Topics: Amphotericin B; Antifungal Agents; Candida; Chile; Cohort Studies; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2012 |
Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Caspofungin; CD4 Lymphocyte Count; Echinocandins; Female; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; L-Lactate Dehydrogenase; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole | 2012 |
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Candidemia; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
[Efficacy of voriconazole treatment in chronic vulvovaginal candidosis due to Candida glabrata].
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis, Vulvovaginal; Cesarean Section; Drug Evaluation; Drug Resistance, Multiple, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Pregnancy; Puerperal Disorders; Pyrimidines; Recurrence; Species Specificity; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
The use of group sequential designs with common competing risks tests.
Topics: Blood Platelets; Clinical Trials as Topic; Computer Simulation; Cord Blood Stem Cell Transplantation; Fluconazole; Humans; Kidney Diseases; Pyrimidines; Research Design; Risk; Sample Size; Statistics as Topic; Triazoles; Voriconazole | 2013 |
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
Topics: Antifungal Agents; Australia; Cryptococcosis; Cryptococcus gattii; Drug Resistance, Fungal; Europe; Fluconazole; Humans; India; Itraconazole; Microbial Sensitivity Tests; North America; Pyrimidines; South Africa; South America; Triazoles; Voriconazole | 2012 |
Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Echinocandins; Female; Fluconazole; HIV Infections; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Mouth; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Pyrimidines; Triazoles; Voriconazole | 2012 |
Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caspofungin; Colony Count, Microbial; Dentures; Diabetes Complications; Echinocandins; Female; Fluconazole; Humans; Hypertension; Kidney Failure, Chronic; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Mycology; Nystatin; Phenotype; Pyrimidines; Renal Dialysis; Time Factors; Triazoles; Voriconazole | 2013 |
Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.
Topics: Amino Acid Sequence; Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Pyrimidines; Saccharomyces cerevisiae; Steroid Isomerases; Sterols; Triazoles; Voriconazole | 2012 |
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.
Topics: Antifungal Agents; China; Cross Infection; Drug Resistance, Fungal; Epidemiological Monitoring; Fluconazole; Humans; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2012 |
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Cyclosporine; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2012 |
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Design, synthesis, and biological evaluation of novel 1, 2, 4-triazole derivatives as antifungal agent.
Topics: Antifungal Agents; Candida albicans; Chromatography, Liquid; Drug Design; Fluconazole; Fungi; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Triazoles | 2012 |
STB5 is a negative regulator of azole resistance in Candida glabrata.
Topics: Amino Acid Sequence; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida glabrata; DNA-Binding Proteins; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Deletion; Gene Expression Regulation, Fungal; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Oxidative Stress; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Alignment; Transcription Factors; Triazoles; Voriconazole | 2013 |
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole | 2013 |
Adapting a global cost-effectiveness model to local country requirements: posaconazole case study.
Topics: Antifungal Agents; Cost-Benefit Analysis; Developed Countries; Drug Therapy, Combination; Fluconazole; Fungi; Humans; Itraconazole; Models, Economic; Mycoses; Triazoles | 2013 |
Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.
Topics: Antifungal Agents; Candida albicans; Clotrimazole; Escherichia coli; Fluconazole; Fungal Proteins; Humans; Itraconazole; Ketoconazole; Kinetics; Lanosterol; NADP; Protein Binding; Pyrimidines; Recombinant Proteins; Species Specificity; Sterol 14-Demethylase; Triazoles; Voriconazole | 2013 |
Prevalence of yeast other than Candida albicans in denture wearers.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Dentures; DNA Fingerprinting; Female; Fluconazole; Humans; Male; Microbial Interactions; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Oral Hygiene; Polymerase Chain Reaction; Prospective Studies; Pyrimidines; RNA, Fungal; RNA, Ribosomal; RNA, Transfer; Triazoles; Voriconazole | 2013 |
Differential pulse polarographic investigation of the antifungal drugs itraconazole, ketoconazole, fluconazole and voriconazole using a dropping mercury electrode.
Topics: Antifungal Agents; Electrochemistry; Electrodes; Fluconazole; Hydrogen-Ion Concentration; Indicators and Reagents; Itraconazole; Ketoconazole; Mercury; Polarography; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole | 2012 |
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Voriconazole suppresses the growth of Leishmania species in vitro.
Topics: Animals; Antiprotozoal Agents; Fluconazole; Inhibitory Concentration 50; Ketoconazole; Leishmania; Parasitic Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2013 |
Posaconazole vs fluconazole/itraconazole in the prophylaxis of invasive fungal infections in immunocompromised patients: a cost-effectiveness analysis in Greece.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Greece; Health Expenditures; Humans; Immunocompromised Host; Itraconazole; Models, Economic; Mycoses; Neutropenia; Triazoles | 2013 |
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Consolidation Chemotherapy; Economics, Pharmaceutical; Female; Fluconazole; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Microbial Sensitivity Tests; Nitriles; Phenotype; Phylogeny; Polymerase Chain Reaction; Pyridines; Pyrimidines; Sequence Analysis, DNA; Tertiary Care Centers; Triazoles; Voriconazole; Young Adult | 2013 |
Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation.
Topics: Antifungal Agents; Cancer Care Facilities; Confidence Intervals; Cost-Benefit Analysis; Fluconazole; Health Resources; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Observational Studies as Topic; Spain; Triazoles | 2013 |
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.
Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Candida; Candidiasis; Fluconazole; Lepidoptera; Pyrimidines; Triazoles; Voriconazole | 2013 |
Species distribution and drug susceptibilities of Candida isolates in TSARY 2010.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candida; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole | 2013 |
Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
Topics: Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azoles; Base Sequence; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polyenes; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Analysis, DNA; Triazoles; Tunisia; Voriconazole | 2013 |
Synthesis and antifungal activity of the novel triazole derivatives containing 1,2,3-triazole fragment.
Topics: Antifungal Agents; Fluconazole; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2013 |
In vitro fluconazole and voriconazole susceptibilities of Candida bloodstream isolates in Korea: use of the CLSI and EUCAST epidemiological cutoff values.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Triazoles; Voriconazole | 2013 |
Dose-response involvement of constitutive androstane receptor in mouse liver hypertrophy induced by triazole fungicides.
Topics: Animals; Constitutive Androstane Receptor; Dose-Response Relationship, Drug; Enzyme Induction; Fluconazole; Fungicides, Industrial; Hepatomegaly; Liver; Male; Mice; Mice, Inbred C3H; Mice, Knockout; Phenobarbital; Receptors, Cytoplasmic and Nuclear; Triazoles | 2013 |
Candida urinary tract infection and Candida species susceptibilities to antifungal agents.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Flucytosine; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Urinary Tract Infections; Voriconazole | 2013 |
Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Topics: Antifungal Agents; Candida; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2013 |
Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Dried Blood Spot Testing; Drug Monitoring; Fluconazole; Humans; Middle Aged; Mucormycosis; Mycoses; Triazoles; Young Adult | 2013 |
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult | 2014 |
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia.
Topics: Allografts; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Substitution; Fatal Outcome; Female; Fluconazole; Fungemia; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Scedosporium; Triazoles; Voriconazole; Young Adult | 2013 |
In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole | 2013 |
Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Fluconazole; Injections, Intraperitoneal; Kidney; Liver; Male; Mice; Mice, Inbred BALB C; Spleen; Treatment Outcome; Triazoles; Trichosporon; Trichosporonosis | 2014 |
Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.
Topics: Antifungal Agents; Candida; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2014 |
Antibiotics sensitivity of Candida clinical and food-borne isolates.
Topics: Candida; Caspofungin; Drug Resistance, Bacterial; Echinocandins; Fluconazole; Food Microbiology; Foodborne Diseases; Humans; Lipopeptides; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2013 |
Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in Sweden.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Life Expectancy; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Quality of Life; Quality-Adjusted Life Years; Sweden; Triazoles | 2014 |
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Algorithms; Antifungal Agents; Azoles; Drug Dosage Calculations; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Sirolimus; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2015 |
Triazole-induced toxicity in developing rare minnow (Gobiocypris rarus) embryos.
Topics: Acetylcholinesterase; Adenosine Triphosphatases; Animals; Cyprinidae; Embryo, Nonmammalian; Epoxy Compounds; Fish Proteins; Fluconazole; Fungicides, Industrial; Gene Expression; Glutathione Transferase; Imidazoles; Nitriles; Silanes; Superoxide Dismutase; Triazoles; Water Pollutants, Chemical | 2014 |
Environmental azole fungicide, prochloraz, can induce cross-resistance to medical triazoles in Candida glabrata.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida glabrata; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungicides, Industrial; Imidazoles; Microbial Sensitivity Tests; Transcription Factors; Triazoles | 2014 |
Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity.
Topics: Antifungal Agents; Chemistry Techniques, Synthetic; Fluconazole; Fungi; Microbial Sensitivity Tests; Models, Molecular; Stereoisomerism; Triazoles | 2015 |
From antidiabetic to antifungal: discovery of highly potent triazole-thiazolidinedione hybrids as novel antifungal agents.
Topics: Antifungal Agents; Binding Sites; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Fungi; Hydrogen Bonding; Hypoglycemic Agents; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Structure, Tertiary; Sterol 14-Demethylase; Structure-Activity Relationship; Thiazolidinediones; Triazoles | 2014 |
Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Fungemia; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Romania; Saccharomyces cerevisiae; Triazoles; Voriconazole; Yeasts; Young Adult | 2015 |
Study the interactions between human serum albumin and two antifungal drugs: fluconazole and its analogue DTP.
Topics: Antifungal Agents; Binding Sites; Circular Dichroism; Fluconazole; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Protein Binding; Protein Conformation; Serum Albumin; Spectrometry, Fluorescence; Thermodynamics; Triazoles | 2014 |
Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antifungal Agents; Child; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Retrospective Studies; Taiwan; Treatment Outcome; Triazoles; Young Adult | 2016 |
An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States.
Topics: Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid; Mycoses; Triazoles; United States | 2015 |
Involvement of constitutive androstane receptor in liver hypertrophy and liver tumor development induced by triazole fungicides.
Topics: Alanine Transaminase; Animals; Aryl Hydrocarbon Hydroxylases; Cell Proliferation; Constitutive Androstane Receptor; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP3A; Cytochrome P450 Family 2; Diethylnitrosamine; Fluconazole; Fungicides, Industrial; Hepatocytes; Hepatomegaly; Liver; Liver Neoplasms, Experimental; Male; Membrane Proteins; Mice; Mice, Inbred C3H; Mice, Knockout; Organ Size; Proto-Oncogene Proteins c-mdm2; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Steroid Hydroxylases; Triazoles | 2015 |
Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Fluconazole; Humans; Incidence; Infant; Itraconazole; Male; Mycoses; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Triazoles | 2015 |
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Candida; China; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mutation; Rhodotorula; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole | 2015 |
Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents.
Topics: Antifungal Agents; Cell Survival; Drug Evaluation, Preclinical; Fluconazole; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Triazoles | 2015 |
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole | 2015 |
Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Fluconazole; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pre-Exposure Prophylaxis; Remission Induction; Retrospective Studies; Survival Analysis; Triazoles | 2016 |
Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51).
Topics: 14-alpha Demethylase Inhibitors; Acanthamoeba castellanii; Amebiasis; Amebicides; Antifungal Agents; Azoles; Cell Proliferation; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Sterol 14-Demethylase; Triazoles; Voriconazole | 2015 |
Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Candida albicans; Crystallography, X-Ray; Drug Resistance, Multiple, Fungal; Fluconazole; Hydrogen Bonding; Lanosterol; Saccharomyces cerevisiae; Sterol 14-Demethylase; Triazoles | 2015 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Cost Savings; Cost-Benefit Analysis; Drug Costs; Female; Fluconazole; Hospital Costs; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Primary Prevention; Propensity Score; Remission Induction; Republic of Korea; Retrospective Studies; Triazoles | 2015 |
Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Humans; Incidence; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Remission Induction; Republic of Korea; Retrospective Studies; Time Factors; Triazoles | 2015 |
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hong Kong; Hospitals, Teaching; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Socioeconomic Factors; Triazoles | 2016 |
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
Topics: Agar; Animals; Antifungal Agents; Culture Media; Disease Models, Animal; Drosophila melanogaster; Female; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Survival Analysis; Triazoles; Virulence; Voriconazole | 2015 |
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Topics: Alleles; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candida glabrata; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Nitriles; Protein Isoforms; Pyridines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole | 2016 |
Uptake of azoles by lamb's lettuce (Valerianella locusta L.) grown in hydroponic conditions.
Topics: Antifungal Agents; Chromatography, Liquid; Clotrimazole; Fluconazole; Hydroponics; Plant Leaves; Plant Roots; Tandem Mass Spectrometry; Triazoles; Valerianella | 2016 |
A combination approach to treating fungal infections.
Topics: Antifungal Agents; Candida albicans; Cell Line, Tumor; Cell Survival; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Epithelial Cells; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Tobramycin; Triazoles; Voriconazole | 2015 |
Cross-resistance to fluconazole induced by exposure to the agricultural azole tetraconazole: an environmental resistance school?
Topics: Animals; Anti-Allergic Agents; Antifungal Agents; ATP-Binding Cassette Transporters; Candida; Chlorobenzenes; Drug Resistance, Microbial; Ergosterol; Fluconazole; Fungicides, Industrial; Gene Expression Regulation, Fungal; Humans; Itraconazole; Malathion; Microbial Sensitivity Tests; Promethazine; Rhodamines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2016 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole | 2016 |
[Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Triazoles; Turkey; Voriconazole | 2016 |
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States | 2016 |
Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Phenotype; Sequence Analysis, DNA; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2016 |
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole | 2016 |
Etiologic Agents and Antifungal Susceptibility of Oral Candidosis from Romanian patients with HIV-infection or type 1 diabetes mellitus.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Diabetes Complications; Diabetes Mellitus, Type 1; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests; Romania; Triazoles | 2016 |
Susceptibility to antifungal agents and enzymatic activity of Candida haemulonii and Cutaneotrichosporon dermatis isolated from soft corals on the Brazilian reefs.
Topics: Animals; Anthozoa; Antifungal Agents; Basidiomycota; Brazil; Candida; DNA, Ribosomal; Drug Resistance, Multiple, Fungal; Esterases; Fluconazole; Gelatinases; Humans; Imidazoles; Microbial Sensitivity Tests; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles | 2016 |
Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; HEK293 Cells; Hemolysis; Heterocyclic Compounds, 2-Ring; Humans; Itraconazole; Mice; Microbial Sensitivity Tests; Reactive Oxygen Species; Structure-Activity Relationship; Thiazoles; Triazoles; Voriconazole | 2016 |
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.
Topics: Adult; Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Itraconazole; Spain; Triazoles; Voriconazole | 2017 |
Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adolescent; Adult; Aged; Allografts; Antifungal Agents; Blood Donors; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Premedication; Salvage Therapy; Survival Analysis; Triazoles; Young Adult | 2016 |
Effect of novel triazole-amino acid hybrids on growth and virulence of Candida species: in vitro and in vivo studies.
Topics: Amino Acids; Antifungal Agents; Candida; Candidiasis; Fluconazole; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Sterol 14-Demethylase; Triazoles; Virulence | 2016 |
In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species.
Topics: Antifungal Agents; Azoles; Candida; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Triazoles | 2017 |
A rapid UPLC-MS/MS assay for the simultaneous measurement of fluconazole, voriconazole, posaconazole, itraconazole, and hydroxyitraconazole concentrations in serum.
Topics: Antifungal Agents; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Fluconazole; Humans; Itraconazole; Limit of Detection; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors; Triazoles; Voriconazole | 2017 |
Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Female; Firefly Luciferin; Fluconazole; Genes, Reporter; High-Throughput Screening Assays; Leishmania major; Leishmaniasis, Cutaneous; Luciferases; Luminescent Measurements; Macrophages; Meglumine; Meglumine Antimoniate; Mesocricetus; Mice; Mice, Inbred BALB C; Ofloxacin; Optical Imaging; Organisms, Genetically Modified; Organometallic Compounds; Triazoles | 2017 |
Changing epidemiology of candidaemia in Australia.
Topics: Anidulafungin; Antifungal Agents; Australia; Azoles; Candida; Candida glabrata; Candida tropicalis; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole | 2017 |
A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Infant; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Peru; Prospective Studies; Triazoles; Voriconazole; Young Adult | 2017 |
Antifungal prophylaxis in newly diagnosed AML patients-Adherence to guidelines and feasibility in a real life setting.
Topics: Adult; Aged; Antifungal Agents; Female; Fluconazole; Galactose; Guideline Adherence; Guidelines as Topic; Humans; Leukemia, Myeloid, Acute; Male; Mannans; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Retrospective Studies; Triazoles | 2017 |
Topics: Antifungal Agents; Azoles; Candida tropicalis; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Humans; Microbial Sensitivity Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Triazoles | 2017 |
Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Topics: Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Spain; Tablets; Triazoles | 2018 |
Design, Synthesis, and Biological Activity of New Triazole and Nitro-Triazole Derivatives as Antifungal Agents.
Topics: Antifungal Agents; Arthrodermataceae; Aspergillus; Catalytic Domain; Drug Evaluation, Preclinical; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Triazoles | 2017 |
Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum.
Topics: Acetonitriles; Adult; Antifungal Agents; Calibration; Chromatography, Liquid; Drug Monitoring; Female; Fluconazole; Humans; Indicators and Reagents; Isotope Labeling; Itraconazole; Nitriles; Plasma; Pyridines; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2017 |
Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain.
Topics: Adult; Aged; Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Humans; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Myelodysplastic Syndromes; Solutions; Spain; Tablets; Triazoles | 2017 |
Topics: Antifungal Agents; Candida; Caspofungin; Drug Interactions; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Treatment Outcome; Triazoles; Young Adult | 2018 |
Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Fungicides, Industrial; Male; Mice, Inbred C57BL; Microbial Sensitivity Tests; Triazoles; Virulence | 2018 |
Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Hospitals, University; Humans; Immunocompromised Host; Iran; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
In vitro activity of isavuconazole against fluconazole-resistant isolates of Histoplasma capsulatum.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Histoplasma; Histoplasmosis; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Recurrence; Triazoles | 2018 |
Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.
Topics: Adolescent; Antifungal Agents; Candida; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Fluconazole; Humans; Kluyveromyces; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Nitriles; Opportunistic Infections; Pichia; Pyridines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole | 2018 |
Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Cryptococcus gattii; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Triazoles | 2018 |
Photodynamic Inactivation Potentiates the Susceptibility of Antifungal Agents against the Planktonic and Biofilm Cells of Candida albicans.
Topics: Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Fluconazole; Humans; Light; Microbial Sensitivity Tests; Photochemotherapy; Plankton; Tolonium Chloride; Triazoles | 2018 |
Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
Topics: Acetaminophen; Analgesics; Antifungal Agents; Aspirin; Candida; Candida albicans; Candida glabrata; Candidiasis; Dipyrone; Drug Resistance, Fungal; Fluconazole; Humans; Ibuprofen; Itraconazole; Meloxicam; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; China; Cost-Benefit Analysis; Female; Fluconazole; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2018 |
Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51.
Topics: Antifungal Agents; Aspergillus fumigatus; Binding Sites; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Drug Design; Drug Resistance, Fungal; Drug Stability; Fluconazole; Fungal Proteins; Gas Chromatography-Mass Spectrometry; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Isoforms; Sterol 14-Demethylase; Sterols; Structure-Activity Relationship; Triazoles | 2018 |
Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candida glabrata; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Itraconazole; Lanosterol; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Sterol 14-Demethylase; Triazoles; Voriconazole | 2018 |
Crystal Structures of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provide Tools for Antifungal Discovery.
Topics: Antifungal Agents; Azoles; Candida albicans; Candida glabrata; Catalytic Domain; Fluconazole; Fungal Proteins; Humans; Itraconazole; Lanosterol; Microbial Sensitivity Tests; Protein Binding; Saccharomyces cerevisiae; Sterol 14-Demethylase; Triazoles | 2018 |
Phenotypic Screens Reveal Posaconazole as a Rapidly Acting Amebicidal Combination Partner for Treatment of Primary Amoebic Meningoencephalitis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Azithromycin; Central Nervous System Protozoal Infections; Disease Models, Animal; Drug Combinations; Drug Discovery; Drug Synergism; Female; Fluconazole; Humans; Inhibitory Concentration 50; Mice; Naegleria fowleri; Phenotype; Time Factors; Triazoles; United States; United States Food and Drug Administration | 2019 |
APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental
Topics: Aminopyridines; Amphotericin B; Animals; Antifungal Agents; Coccidioides; Disease Models, Animal; Female; Fluconazole; Isoxazoles; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia; Prodrugs; Triazoles | 2019 |
Impact of Antifungal Compounds on Viability and Anti-
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cell Survival; Deoxycholic Acid; Doxorubicin; Drug Combinations; Fluconazole; Humans; Killer Cells, Natural; Microbial Sensitivity Tests; Polyethylene Glycols; Triazoles; Voriconazole | 2019 |
Yeast-like filamentous fungi: Molecular identification and in vitro susceptibility study.
Topics: Antifungal Agents; DNA, Fungal; Fluconazole; Fungi; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
Predicting the Effects of Different Triazole Antifungal Agents on the Pharmacokinetics of Tamoxifen.
Topics: Antifungal Agents; Bone Density Conservation Agents; Drug Interactions; Female; Fluconazole; Forecasting; Humans; Itraconazole; Middle Aged; Models, Biological; Tamoxifen; Triazoles; Voriconazole | 2019 |
Abrogation of Triazole Resistance upon Deletion of
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida; Candidiasis; CRISPR-Associated Protein 9; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Deletion; Gene Expression Regulation, Fungal; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Microorganisms, Genetically-Modified; Triazoles | 2019 |
Isavuconazole MIC distribution of 29 yeast species responsible for invasive infections (2015-2017).
Topics: Antifungal Agents; Fluconazole; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Yeasts | 2019 |
The Evolution of Azole Resistance in
Topics: Amino Acid Sequence; Antifungal Agents; Azoles; Candida albicans; Fluconazole; Fungal Proteins; Itraconazole; Mutation; Protein Binding; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
First fungemia case due to environmental yeast Wickerhamomyces myanmarensis: detection by multiplex qPCR and antifungal susceptibility.
Topics: Antifungal Agents; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Male; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Saccharomycetales; Triazoles; Voriconazole | 2019 |
Cis-2-dodecenoic Acid Mediates Its Synergistic Effect with Triazoles by Interfering with Efflux Pumps in Fluconazole-resistant Candida albicans.
Topics: Antifungal Agents; Burkholderia cenocepacia; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fatty Acids, Monounsaturated; Fluconazole; Humans; Microbial Sensitivity Tests; Triazoles | 2019 |
Immune reconstitution inflammatory syndrome in an HIV-infected patient with disseminated coccidioidomycosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Coccidioidomycosis; Fluconazole; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Prednisone; Treatment Outcome; Triazoles | 2019 |
Comparison of the inhibitory effect of ketoconazole, voriconazole, fluconazole, and itraconazole on the pharmacokinetics of bosentan and its corresponding active metabolite hydroxy bosentan in rats.
Topics: Animals; Antifungal Agents; Antihypertensive Agents; Bosentan; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Male; Rats; Rats, Sprague-Dawley; Triazoles; Voriconazole | 2020 |
Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Disk Diffusion Antimicrobial Tests; Econazole; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Pemphigus; Triazoles | 2019 |
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
The antiproliferative peptide Ctn[15-34] is active against multidrug-resistant yeasts Candida albicans and Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Peptide Fragments; Triazoles | 2020 |
In vitro synergy of echinocandins with triazoles against fluconazole-resistant Candida parapsilosis complex isolates.
Topics: Antifungal Agents; Candida parapsilosis; Echinocandins; Fluconazole; Microbial Sensitivity Tests; Triazoles | 2020 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |
Agricultural systems as potential sources of emerging human mycoses caused by Trichoderma: a successful, common phylotype of Trichoderma longibrachiatum in the frontline.
Topics: Agriculture; Antifungal Agents; Environmental Exposure; Environmental Microbiology; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mycological Typing Techniques; Mycoses; Phylogeny; Triazoles; Trichoderma | 2019 |
Simultaneous quantitation of five triazole anti-fungal agents by paper spray-mass spectrometry.
Topics: Antifungal Agents; Dried Blood Spot Testing; Drug Monitoring; Fluconazole; Humans; Isotope Labeling; Laboratories; Limit of Detection; Paper; Reference Standards; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2020 |
Design, synthesis, and structure-activity relationship studies of novel triazole agents with strong antifungal activity against Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillus fumigatus; Binding Sites; Candida albicans; Catalytic Domain; Drug Design; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2020 |
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole | 2020 |
Disseminated Lomentospora prolificans infection in a patient on idelalisib-rituximab therapy for relapsed chronic lymphocytic leukaemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance, Multiple, Fungal; Drug Substitution; Fatal Outcome; Febrile Neutropenia; Female; Filgrastim; Fluconazole; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Piperacillin, Tazobactam Drug Combination; Purines; Quinazolinones; Recurrence; Rituximab; Scedosporium; Triazoles; Valacyclovir; Vidarabine | 2020 |
In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.
Topics: Amphotericin B; Antifungal Agents; China; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycelium; Phylogeny; Saccharomyces cerevisiae; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 2021 |
Evaluating the Effect of Azole Antifungal Agents on the Stress Response and Nanomechanical Surface Properties of
Topics: Anti-Bacterial Agents; Azoles; Bacterial Adhesion; Biomechanical Phenomena; Cell Membrane Permeability; Clotrimazole; Epoxy Compounds; Fluconazole; Glutathione; Hydrophobic and Hydrophilic Interactions; Imidazoles; Microbial Sensitivity Tests; Microscopy, Atomic Force; Nanoparticles; Ochrobactrum anthropi; Surface Properties; Triazoles | 2020 |
Posaconazole and fluconazole prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Child; Child, Preschool; Female; Fluconazole; Humans; Induction Chemotherapy; Invasive Fungal Infections; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Treatment Outcome; Triazoles | 2021 |
Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Caspofungin; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Rhodotorula; Species Specificity; Triazoles; Voriconazole | 2020 |
Absolute Configuration, Enantioselective Bioactivity, and Degradation of the Novel Chiral Triazole Fungicide Mefentrifluconazole.
Topics: Chromatography, Liquid; Fluconazole; Fungicides, Industrial; Molecular Docking Simulation; Soil Pollutants; Stereoisomerism; Tandem Mass Spectrometry; Triazoles | 2021 |
Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations.
Topics: Antifungal Agents; Cyclosporine; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Nitriles; Pyridines; Retrospective Studies; Tacrolimus; Triazoles | 2022 |
Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antimicrobial Stewardship; Candida; Caspofungin; Child; Child, Preschool; Colony Count, Microbial; Disease Susceptibility; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Triazoles | 2021 |
Impact of Erg11 Amino Acid Substitutions Identified in Candida auris Clade III Isolates on Triazole Drug Susceptibility.
Topics: Amino Acid Substitution; Antifungal Agents; Candida auris; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Triazoles | 2022 |
Posaconazole treatment of refractory coccidioidomycosis in dogs.
Topics: Animals; Antifungal Agents; Coccidioidomycosis; Dog Diseases; Dogs; Fluconazole; Retrospective Studies; Triazoles | 2021 |
Urea-thiazole/benzothiazole hybrids with a triazole linker: synthesis, antimicrobial potential, pharmacokinetic profile and in silico mechanistic studies.
Topics: Alkynes; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Benzothiazoles; Candida albicans; Escherichia coli; Fluconazole; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Sterols; Structure-Activity Relationship; Triazoles; Urea | 2022 |
Synthesis of fish scale derived hydroxyapatite silica propyl bis aminoethoxy ethane cuprous complex (HASPBAEECC) as a novel hybrid nano-catalyst for highly efficient synthesis of new benzimidazole-1,2,3-triazole hybrid analogues as antifungal agents.
Topics: Animals; Antifungal Agents; Benzimidazoles; Candida albicans; Durapatite; Ethane; Fluconazole; Silicon Dioxide; Spectroscopy, Fourier Transform Infrared; Triazoles; Water | 2022 |
Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib.
Topics: Antifungal Agents; Carcinoma, Non-Small-Cell Lung; Crizotinib; Fluconazole; Humans; Itraconazole; Lung Neoplasms; Triazoles; Voriconazole | 2022 |
Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia.
Topics: Adult; Fluconazole; Humans; Leukemia, Promyelocytic, Acute; Male; Papilledema; Pseudotumor Cerebri; Tretinoin; Triazoles; Voriconazole; Young Adult | 2022 |
Acquisition of cross-azole tolerance and aneuploidy in Candida albicans strains evolved to posaconazole.
Topics: Aneuploidy; Antifungal Agents; Azoles; Candida albicans; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Triazoles | 2022 |
In vitro synergistic antifungal activities of caspofungin in combination with fluconazole or voriconazole against Candida species determined by the Etest method.
Topics: Antifungal Agents; Candida; Candida glabrata; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2022 |
In silico identification of 1,2,4-triazoles as potential Candida Albicans inhibitors using 3D-QSAR, molecular docking, molecular dynamics simulations, and ADMET profiling.
Topics: Candida albicans; Fluconazole; Molecular Docking Simulation; Molecular Dynamics Simulation; Quantitative Structure-Activity Relationship; Triazoles | 2023 |
Design, synthesis, and in vitro evaluation of novel antifungal triazoles containing substituted 1,2,3-triazole-methoxyl side chains.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Structure-Activity Relationship; Triazoles | 2022 |
Design, synthesis and antifungal activities of novel triazole derivatives with selenium-containing hydrophobic side chains.
Topics: Animals; Antifungal Agents; Fluconazole; Humans; Invasive Fungal Infections; Mammals; Selenium; Triazoles | 2022 |
Permeability of New Antifungal Fluconazole Derivatives through a Lipophilic Membrane: Experiment and Modeling.
Topics: Antifungal Agents; Drug Design; Fluconazole; Permeability; Solubility; Triazoles | 2023 |
In vitro activity of isavuconazole against clinically relevant Trichosporon species: a comparative evaluation of EUCAST broth microdilution and MIC Test Strip methods.
Topics: Antifungal Agents; Fluconazole; Microbial Sensitivity Tests; Triazoles; Trichosporon; Voriconazole | 2023 |
Design, synthesis and biological activity of hybrid antifungals derived from fluconazole and mebendazole.
Topics: Antifungal Agents; Candida; Fluconazole; Mebendazole; Microbial Sensitivity Tests; Structure-Activity Relationship; Triazoles | 2023 |
Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.
Topics: Antifungal Agents; Arthrodermataceae; Caspofungin; Fluconazole; Griseofulvin; Hospitals, University; Humans; Iran; Itraconazole; Terbinafine; Triazoles | 2023 |
Novel antifungal triazoles with alkynyl-methoxyl side chains: Design, synthesis, and biological activity evaluation.
Topics: Antifungal Agents; Candida albicans; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Saccharomyces cerevisiae; Triazoles | 2023 |
Novel Triazoles with Potent and Broad-Spectrum Antifungal Activity In Vitro and In Vivo.
Topics: Antifungal Agents; Azoles; Candida albicans; Fluconazole; Microbial Sensitivity Tests; Triazoles | 2023 |